BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89:147-191. [PMID: 19126757 DOI: 10.1152/physrev.00010.2008] [Cited by in Crossref: 957] [Cited by in F6Publishing: 915] [Article Influence: 73.6] [Reference Citation Analysis]
Number Citing Articles
1 Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol. 2017;101:47-64. [PMID: 27888332 DOI: 10.1007/s00253-016-8006-6] [Cited by in Crossref: 184] [Cited by in F6Publishing: 159] [Article Influence: 30.7] [Reference Citation Analysis]
2 Chen J, Huang X. The effects of diets enriched in beta-glucans on blood lipoprotein concentrations. Journal of Clinical Lipidology 2009;3:154-8. [DOI: 10.1016/j.jacl.2009.04.054] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
3 Liu JL, Desjardins D, Branicky R, Agellon LB, Hekimi S. Mitochondrial oxidative stress alters a pathway in Caenorhabditis elegans strongly resembling that of bile acid biosynthesis and secretion in vertebrates. PLoS Genet 2012;8:e1002553. [PMID: 22438816 DOI: 10.1371/journal.pgen.1002553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
4 Byun S, Kim DH, Ryerson D, Kim YC, Sun H, Kong B, Yau P, Guo G, Xu HE, Kemper B, Kemper JK. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis. Nat Commun. 2018;9:2590. [PMID: 29968724 DOI: 10.1038/s41467-018-04697-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
5 Pollak NM, Hoffman M, Goldberg IJ, Drosatos K. Krüppel-like factors: Crippling and un-crippling metabolic pathways. JACC Basic Transl Sci 2018;3:132-56. [PMID: 29876529 DOI: 10.1016/j.jacbts.2017.09.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
6 Suga T, Yamaguchi H, Ogura J, Shoji S, Maekawa M, Mano N. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis. Toxicol Appl Pharmacol 2019;379:114664. [PMID: 31306673 DOI: 10.1016/j.taap.2019.114664] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
7 Ghoneim RH, Ngo Sock ET, Lavoie JM, Piquette-Miller M. Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition. Br J Nutr 2015;113:507-16. [PMID: 25612518 DOI: 10.1017/S0007114514003717] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
8 Hajeyah AA, Griffiths WJ, Wang Y, Finch AJ, O'Donnell VB. The Biosynthesis of Enzymatically Oxidized Lipids. Front Endocrinol (Lausanne) 2020;11:591819. [PMID: 33329396 DOI: 10.3389/fendo.2020.591819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
9 Sadler NC, Webb-Robertson BM, Clauss TR, Pounds JG, Corley R, Wright AT. High-Fat Diets Alter the Modulatory Effects of Xenobiotics on Cytochrome P450 Activities. Chem Res Toxicol 2018;31:308-18. [PMID: 29688711 DOI: 10.1021/acs.chemrestox.8b00008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
10 Ma J, Hong Y, Zheng N, Xie G, Lyu Y, Gu Y, Xi C, Chen L, Wu G, Li Y, Tao X, Zhong J, Huang Z, Wu W, Yuan L, Lin M, Lu X, Zhang W, Jia W, Sheng L, Li H. Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically. Gut Microbes 2020;11:1450-74. [PMID: 32515683 DOI: 10.1080/19490976.2020.1763770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
11 Chen L, Yao X, Young A, McNulty J, Anderson D, Liu Y, Nystrom C, Croom D, Ross S, Collins J, Rajpal D, Hamlet K, Smith C, Gedulin B. Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes. Am J Physiol Endocrinol Metab 2012;302:E68-76. [PMID: 21934041 DOI: 10.1152/ajpendo.00323.2011] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
12 Murphy EJ, Rezoagli E, Major I, Rowan NJ, Laffey JG. β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application. J Fungi (Basel) 2020;6:E356. [PMID: 33322069 DOI: 10.3390/jof6040356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
13 Wang K, Chan MY, Xu J, Li P, Liu X, Lee AY, Lee SS, Cheung W. Male-biased fasting-induced changes in hepatic tauro-cholic acid and plasma cholesterol in Sult2a8-haplodeficient mice. Transgenic Res 2020;29:499-510. [DOI: 10.1007/s11248-020-00215-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Schupp AK, Trilling M, Rattay S, Le-Trilling VTK, Haselow K, Stindt J, Zimmermann A, Häussinger D, Hengel H, Graf D. Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes. J Virol 2016;90:6686-98. [PMID: 27170759 DOI: 10.1128/JVI.00299-16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Proffitt C, Bidkhori G, Moyes D, Shoaie S. Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions. Microorganisms 2020;8:E1381. [PMID: 32916966 DOI: 10.3390/microorganisms8091381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rajendiran E, Ramadass B, Ramprasath V. Understanding connections and roles of gut microbiome in cardiovascular diseases. Can J Microbiol 2021;67:101-11. [PMID: 33079568 DOI: 10.1139/cjm-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Monaghan T, Mullish BH, Patterson J, Wong GK, Marchesi JR, Xu H, Jilani T, Kao D. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Gut Microbes 2019;10:142-8. [PMID: 30183484 DOI: 10.1080/19490976.2018.1506667] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
18 Goldberg AA, Richard VR, Kyryakov P, Bourque SD, Beach A, Burstein MT, Glebov A, Koupaki O, Boukh-Viner T, Gregg C, Juneau M, English AM, Thomas DY, Titorenko VI. Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes. Aging (Albany NY) 2010;2:393-414. [PMID: 20622262 DOI: 10.18632/aging.100168] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.3] [Reference Citation Analysis]
19 Franzoni AC, Amorim AM, Silva JVMD, Storti JAP, Oliveira MCD. Use of Ursodeoxycholic Acid on Post-menopausal Obesity, Hepatic steatosis and Plasma Profile as an Alternative Treatment for Hormone Replacement Therapy. Braz arch biol technol 2015;58:898-904. [DOI: 10.1590/s1516-89132015060310] [Reference Citation Analysis]
20 Liu H, Zhang M, Ma Q, Tian B, Nie C, Chen Z, Li J. Health beneficial effects of resistant starch on diabetes and obesity via regulation of gut microbiota: a review. Food Funct 2020;11:5749-67. [PMID: 32602874 DOI: 10.1039/d0fo00855a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
21 Sookoian S, Pirola CJ. The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine. Clin Liver Dis. 2012;16:467-485. [PMID: 22824476 DOI: 10.1016/j.cld.2012.05.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
22 Ito K, Okumura A, Takeuchi JS, Watashi K, Inoue R, Yamauchi T, Sakamoto K, Yamashita Y, Iguchi Y, Une M, Wakita T, Umezawa K, Yoneda M. Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo. Hepatology 2021;74:83-98. [PMID: 33434356 DOI: 10.1002/hep.31712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes Obes Metab 2021;23:1069-83. [PMID: 33464677 DOI: 10.1111/dom.14322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
24 Favretto F, Ceccon A, Zanzoni S, D'Onofrio M, Ragona L, Molinari H, Assfalg M. The unique ligand binding features of subfamily-II iLBPs with respect to bile salts and related drugs. Prostaglandins Leukot Essent Fatty Acids 2015;95:1-10. [PMID: 25468388 DOI: 10.1016/j.plefa.2014.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
25 Lien F, Berthier A, Bouchaert E, Gheeraert C, Alexandre J, Porez G, Prawitt J, Dehondt H, Ploton M, Colin S, Lucas A, Patrice A, Pattou F, Diemer H, Van Dorsselaer A, Rachez C, Kamilic J, Groen AK, Staels B, Lefebvre P. Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. J Clin Invest 2014;124:1037-51. [PMID: 24531544 DOI: 10.1172/JCI68815] [Cited by in Crossref: 87] [Cited by in F6Publishing: 43] [Article Influence: 10.9] [Reference Citation Analysis]
26 Haghbin H, Gangwani MK, Ravi SJK, Perisetti A, Aziz M, Goyal H, Nawras A, Sodeman T. Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions. Ann Gastroenterol 2020;33:603-14. [PMID: 33162737 DOI: 10.20524/aog.2020.0550] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Li B, Hu Y, Wang G, Liu L. The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study. BMC Pharmacol Toxicol 2020;21:44. [PMID: 32539783 DOI: 10.1186/s40360-020-00422-5] [Reference Citation Analysis]
28 Endo S, Matsunaga T, Arai Y, Ikari A, Tajima K, El-kabbani O, Yamano S, Hara A, Kitade Y. Cloning and Characterization of Four Rabbit Aldo-Keto Reductases Featuring Broad Substrate Specificity for Xenobiotic and Endogenous Carbonyl Compounds: Relationship with Multiple Forms of Drug Ketone Reductases. Drug Metab Dispos 2014;42:803-12. [DOI: 10.1124/dmd.113.056044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
29 Lee SG, Lee YH, Choi E, Cho Y, Kim JH. Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status. Clin Chem Lab Med 2019;57:1218-28. [PMID: 30964746 DOI: 10.1515/cclm-2018-0741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Kang SH, Kim MY, Baik SK. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon. Hepatol Int 2018;12:112-21. [DOI: 10.1007/s12072-017-9806-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
31 Kim SY, Kwon YW, Jung IL, Sung JH, Park SG. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction. Cardiovasc Res 2011;92:307-16. [PMID: 21840882 DOI: 10.1093/cvr/cvr219] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
32 Sindhu T, Srinivasan P. Identification of potential dual agonists of FXR and TGR5 using e-pharmacophore based virtual screening. Mol BioSyst 2015;11:1305-18. [DOI: 10.1039/c5mb00137d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
33 Cao Y, Xiao Y, Zhou K, Yan J, Wang P, Yan W, Cai W. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019;317:G108-15. [DOI: 10.1152/ajpgi.00356.2017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
34 Anhê FF, Varin TV, Schertzer JD, Marette A. The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery. Canadian Journal of Diabetes 2017;41:439-47. [DOI: 10.1016/j.jcjd.2017.02.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
35 Kumar S, Palaia T, Hall CE, Ragolia L. Role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) and its metabolite, prostaglandin D2, in preterm birth. Prostaglandins & Other Lipid Mediators 2015;118-119:28-33. [DOI: 10.1016/j.prostaglandins.2015.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Bays HE, Jones PH, Jacobson TA, Cohen DE, Orringer CE, Kothari S, Azagury DE, Morton J, Nguyen NT, Westman EC, Horn DB, Scinta W, Primack C. Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT. Journal of Clinical Lipidology 2016;10:33-57. [DOI: 10.1016/j.jacl.2015.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
37 Theiler-schwetz V, Zaufel A, Schlager H, Obermayer-pietsch B, Fickert P, Zollner G. Bile acids and glucocorticoid metabolism in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:243-51. [DOI: 10.1016/j.bbadis.2018.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Rimoldi S, Benedito-palos L, Terova G, Pérez-sánchez J. Wide-targeted gene expression infers tissue-specific molecular signatures of lipid metabolism in fed and fasted fish. Rev Fish Biol Fisheries 2016;26:93-108. [DOI: 10.1007/s11160-015-9408-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 2.9] [Reference Citation Analysis]
39 Labbé A, Ganopolsky JG, Martoni CJ, Prakash S, Jones ML. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes. PLoS One 2014;9:e115175. [PMID: 25517115 DOI: 10.1371/journal.pone.0115175] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
40 Chen L, McNulty J, Anderson D, Liu Y, Nystrom C, Bullard S, Collins J, Handlon AL, Klein R, Grimes A. Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats. J Pharmacol Exp Ther. 2010;334:164-170. [PMID: 20413600 DOI: 10.1124/jpet.110.166892] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
41 Chiang JY. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191-1212. [PMID: 23897684 DOI: 10.1002/cphy.c120023] [Cited by in Crossref: 200] [Cited by in F6Publishing: 329] [Article Influence: 22.2] [Reference Citation Analysis]
42 Li S, Ni A, Feng GS. Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis. Acta Pharmacol Sin 2015;36:113-8. [PMID: 25500873 DOI: 10.1038/aps.2014.118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
43 Yang Q, Guo X, Chen Y, Zhang W, Ren J, Wang J, Tang N, Gao A. Blood levels of perfluoroalkyl substances (PFASs), elements and their associations with metabolic syndrome (MetS) in Chinese male adults mediated by metabolic-related risk factors. Science of The Total Environment 2020;742:140595. [DOI: 10.1016/j.scitotenv.2020.140595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Zeng BB, Zhang LY, Chen C, Zhang TT, Xue CH, Yanagita T, Li ZJ, Wang YM. Sea Cucumber Sterol Alleviates the Lipid Accumulation in High-Fat-Fructose Diet Fed Mice. J Agric Food Chem 2020;68:9707-17. [PMID: 32786870 DOI: 10.1021/acs.jafc.0c03794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Jones ML, Ganopolsky JG, Martoni CJ, Labbé A, Prakash S. Emerging science of the human microbiome. Gut Microbes 2014;5:446-57. [PMID: 25013912 DOI: 10.4161/gmic.29810] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
46 Fang M, Zhang Q, Yu P, Ge C, Guo J, Zhang Y, Wang H. The effects, underlying mechanism and interactions of dexamethasone exposure during pregnancy on maternal bile acid metabolism. Toxicol Lett 2020;332:97-106. [PMID: 32599024 DOI: 10.1016/j.toxlet.2020.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bachour-El Azzi P, Sharanek A, Burban A, Li R, Guével RL, Abdel-Razzak Z, Stieger B, Guguen-Guillouzo C, Guillouzo A. Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes. Toxicol Sci 2015;145:157-68. [PMID: 25690737 DOI: 10.1093/toxsci/kfv041] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
48 Hu X, Wang Y, Sheikhahmadi A, Li X, Buyse J, Lin H, Song Z. Effects of glucocorticoids on lipid metabolism and AMPK in broiler chickens' liver. Comp Biochem Physiol B Biochem Mol Biol 2019;232:23-30. [PMID: 30790719 DOI: 10.1016/j.cbpb.2019.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
49 Arlia-Ciommo A, Piano A, Leonov A, Svistkova V, Titorenko VI. Quasi-programmed aging of budding yeast: a trade-off between programmed processes of cell proliferation, differentiation, stress response, survival and death defines yeast lifespan. Cell Cycle 2014;13:3336-49. [PMID: 25485579 DOI: 10.4161/15384101.2014.965063] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
50 Pu S, Zhou H, Liu Y, Liu J, Guo Y, Zhou H. Roles of nuclear receptors in hepatic stellate cells. Expert Rev Gastroenterol Hepatol 2021;15:879-90. [PMID: 34225534 DOI: 10.1080/17474124.2021.1949288] [Reference Citation Analysis]
51 Kwong E, Li Y, Hylemon PB, Zhou H. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism. Acta Pharm Sin B 2015;5:151-7. [PMID: 26579441 DOI: 10.1016/j.apsb.2014.12.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
52 Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, Florez JC, Clish CB, Gerszten RE, Wang TJ. Metabolite profiles during oral glucose challenge. Diabetes. 2013;62:2689-2698. [PMID: 23382451 DOI: 10.2337/db12-0754] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 10.9] [Reference Citation Analysis]
53 Manley S, Ding W. Role of farnesoid X receptor and bile acids in alcoholic liver disease. Acta Pharm Sin B. 2015;5:158-167. [PMID: 26579442 DOI: 10.1016/j.apsb.2014.12.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
54 Amigo L, Husche C, Zanlungo S, Lütjohann D, Arrese M, Miquel JF, Rigotti A, Nervi F. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int. 2011;31:52-64. [PMID: 21040411 DOI: 10.1111/j.1478-3231.2010.02361.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
55 Keitel V, Häussinger D. TGR5 in cholangiocytes. Curr Opin Gastroenterol 2013;29:299-304. [PMID: 23429467 DOI: 10.1097/MOG.0b013e32835f3f14] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
56 De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, Rainteau D, Schneiter P, Tappy L, Giusti V. Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study. Clin Nutr. 2015;34:911-917. [PMID: 25306425 DOI: 10.1016/j.clnu.2014.09.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
57 Fiorucci S, Distrutti E. Linking liver metabolic and vascular disease via bile acid signaling. Trends Mol Med 2022;28:51-66. [PMID: 34815180 DOI: 10.1016/j.molmed.2021.10.005] [Reference Citation Analysis]
58 Feng L, Yuen YL, Xu J, Liu X, Chan MY, Wang K, Fong WP, Cheung WT, Lee SS. Identification and characterization of a novel PPARα-regulated and 7α-hydroxyl bile acid-preferring cytosolic sulfotransferase mL-STL (Sult2a8). J Lipid Res 2017;58:1114-31. [PMID: 28442498 DOI: 10.1194/jlr.M074302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
59 Jiao N, Baker SS, Chapa-Rodriguez A, Liu W, Nugent CA, Tsompana M, Mastrandrea L, Buck MJ, Baker RD, Genco RJ, Zhu R, Zhu L. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. Gut. 2018;67:1881-1891. [PMID: 28774887 DOI: 10.1136/gutjnl-2017-314307] [Cited by in Crossref: 166] [Cited by in F6Publishing: 169] [Article Influence: 33.2] [Reference Citation Analysis]
60 Shao D, Wang Y, Huang Q, Shi J, Yang H, Pan Z, Jin M, Zhao H, Xu X. Cholesterol-Lowering Effects and Mechanisms in View of Bile Acid Pathway of Resveratrol and Resveratrol Glucuronides. J Food Sci. 2016; Epub ahead of print. [PMID: 27735997 DOI: 10.1111/1750-3841.13528] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
61 Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851-861. [PMID: 30952999 DOI: 10.1038/s41385-019-0162-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
62 Liu BB, Kong J, Wu SD, Wang Y. Bile acid salt export pump: Molecular mechanisms of transcription and intracellular regulation. Shijie Huaren Xiaohua Zazhi 2014; 22(6): 788-794 [DOI: 10.11569/wcjd.v22.i6.788] [Reference Citation Analysis]
63 Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res 2021;163:105362. [PMID: 33285231 DOI: 10.1016/j.phrs.2020.105362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Comeglio P, Morelli A, Adorini L, Maggi M, Vignozzi L. Beneficial effects of bile acid receptor agonists in pulmonary disease models. Expert Opin Investig Drugs 2017;26:1215-28. [PMID: 28949776 DOI: 10.1080/13543784.2017.1385760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
65 Grevengoed TJ, Klett EL, Coleman RA. Acyl-CoA metabolism and partitioning. Annu Rev Nutr 2014;34:1-30. [PMID: 24819326 DOI: 10.1146/annurev-nutr-071813-105541] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 21.8] [Reference Citation Analysis]
66 Cao R, Cronk ZX, Zha W, Sun L, Wang X, Fang Y, Studer E, Zhou H, Pandak WM, Dent P, Gil G, Hylemon PB. Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway. J Lipid Res 2010;51:2234-44. [PMID: 20305288 DOI: 10.1194/jlr.M004929] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
67 Greiner T, Bäckhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab. 2011;22:117-123. [PMID: 21353592 DOI: 10.1016/j.tem.2011.01.002] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 17.1] [Reference Citation Analysis]
68 Dutta D, Kalra S, Sharma M. Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy. J Postgrad Med 2017;63:114-21. [PMID: 27652986 DOI: 10.4103/0022-3859.191007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Hirschfield GM, Mason A, Luketic V, Lindor K, Gordon SC, Mayo M, Kowdley KV, Vincent C, Bodhenheimer HC, Parés A. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology. 2015;148:751-761.e8. [PMID: 25500425 DOI: 10.1053/j.gastro.2014.12.005] [Cited by in Crossref: 322] [Cited by in F6Publishing: 276] [Article Influence: 40.3] [Reference Citation Analysis]
70 Joyce SA, Kamil A, Fleige L, Gahan CGM. The Cholesterol-Lowering Effect of Oats and Oat Beta Glucan: Modes of Action and Potential Role of Bile Acids and the Microbiome. Front Nutr 2019;6:171. [PMID: 31828074 DOI: 10.3389/fnut.2019.00171] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 9.3] [Reference Citation Analysis]
71 Ho RH, Leake BF, Urquhart BL, Gregor JC, Dawson PA, Kim RB. Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2). J Gastroenterol Hepatol 2011;26:1740-8. [PMID: 21649730 DOI: 10.1111/j.1440-1746.2011.06805.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
72 Porez G, Gross B, Prawitt J, Gheeraert C, Berrabah W, Alexandre J, Staels B, Lefebvre P. The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR. Endocrinology 2013;154:3690-701. [PMID: 23861371 DOI: 10.1210/en.2013-1263] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
73 Downing LE, Edgar D, Ellison PA, Ricketts M. Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE). Cell Biochem Funct 2017;35:12-32. [DOI: 10.1002/cbf.3247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
74 Broeders E, Bouvy ND, van Marken Lichtenbelt WD. Endogenous ways to stimulate brown adipose tissue in humans. Annals of Medicine 2015;47:123-32. [DOI: 10.3109/07853890.2013.874663] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
75 Shaik FB, Prasad DV, Narala VR. Role of farnesoid X receptor in inflammation and resolution. Inflamm Res. 2015;64:9-20. [PMID: 25376338 DOI: 10.1007/s00011-014-0780-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
76 Fiamoncini J, Fernandes Barbosa C, Arnoni Junior JR, Araújo Junior JC, Taglieri C, Szego T, Gelhaus B, Possolo de Souza H, Daniel H, Martins de Lima T. Roux-en-Y Gastric Bypass Surgery Induces Distinct but Frequently Transient Effects on Acylcarnitine, Bile Acid and Phospholipid Levels. Metabolites 2018;8:E83. [PMID: 30477108 DOI: 10.3390/metabo8040083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
77 Mráz M, Lacinová Z, Kaválková P, Haluzíková D, Trachta P, Drápalová J, Hanušová V, Haluzík M. Serum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: the Influence of Acute Hyperinsulinemia, Very-Low Calorie Diet and PPAR-α Agonist Treatment. Physiol Res. [DOI: 10.33549/physiolres.932099] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
78 Morio B, Comte B, Martin J, Chanseaume E, Alligier M, Junot C, Lyan B, Boirie Y, Vidal H, Laville M, Pujos-guillot E, Sébédio J. Metabolomics reveals differential metabolic adjustments of normal and overweight subjects during overfeeding. Metabolomics 2015;11:920-38. [DOI: 10.1007/s11306-014-0750-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
79 Lin S, Yang Z, Liu H, Tang L, Cai Z. Beyond glucose: metabolic shifts in responses to the effects of the oral glucose tolerance test and the high-fructose diet in rats. Mol Biosyst 2011;7:1537-48. [PMID: 21350749 DOI: 10.1039/c0mb00246a] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
80 Li T, Owsley E, Matozel M, Hsu P, Novak CM, Chiang JY. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology. 2010;52:678-690. [PMID: 20623580 DOI: 10.1002/hep.23721] [Cited by in Crossref: 143] [Cited by in F6Publishing: 138] [Article Influence: 11.9] [Reference Citation Analysis]
81 Pellicciari R, Gioiello A, Macchiarulo A, Thomas C, Rosatelli E, Natalini B, Sardella R, Pruzanski M, Roda A, Pastorini E, Schoonjans K, Auwerx J. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J Med Chem. 2009;52:7958-7961. [PMID: 20014870 DOI: 10.1021/jm901390p] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 15.0] [Reference Citation Analysis]
82 Aguilar-olivos NE, Carrillo-córdova D, Oria-hernández J, Sánchez-valle V, Ponciano-rodríguez G, Ramírez-jaramillo M, Chablé-montero F, Chávez-tapia NC, Uribe M, Méndez-sánchez N. The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease. Annals of Hepatology 2015;14:487-93. [DOI: 10.1016/s1665-2681(19)31170-6] [Cited by in Crossref: 42] [Article Influence: 6.0] [Reference Citation Analysis]
83 Cai K, Sewer MB. Diacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes. Biochem J 2013;454:267-74. [PMID: 23767959 DOI: 10.1042/BJ20130609] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
84 Grams J, Garvey WT. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr Obes Rep 2015;4:287-302. [PMID: 26627223 DOI: 10.1007/s13679-015-0155-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
85 Marksteiner J, Blasko I, Kemmler G, Koal T, Humpel C. Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease. Metabolomics 2018;14:1. [PMID: 29249916 DOI: 10.1007/s11306-017-1297-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
86 Li Y, Jadhav K, Zhang Y. Bile acid receptors in non-alcoholic fatty liver disease. Biochem Pharmacol. 2013;86:1517-1524. [PMID: 23988487 DOI: 10.1016/j.bcp.2013.08.015] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
87 Baptissart M, Vega A, Maqdasy S, Caira F, Baron S, Lobaccaro JM, Volle DH. Bile acids: from digestion to cancers. Biochimie. 2013;95:504-517. [PMID: 22766017 DOI: 10.1016/j.biochi.2012.06.022] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
88 Grefhorst A, Verkade HJ, Groen AK. The TICE Pathway: Mechanisms and Lipid-Lowering Therapies. Methodist Debakey Cardiovasc J 2019;15:70-6. [PMID: 31049152 DOI: 10.14797/mdcj-15-1-70] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
89 Tietge UJ, Groen AK. Role the TICE?: advancing the concept of transintestinal cholesterol excretion. Arterioscler Thromb Vasc Biol 2013;33:1452-3. [PMID: 23766383 DOI: 10.1161/ATVBAHA.113.301562] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
90 Gitto S, Guarneri V, Sartini A, Andreone P. The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives. Expert Rev Gastroenterol Hepatol 2018;12:165-71. [PMID: 29082798 DOI: 10.1080/17474124.2018.1399060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
91 Wen J, Mercado GP, Volland A, Doden HL, Lickwar CR, Crooks T, Kakiyama G, Kelly C, Cocchiaro JL, Ridlon JM, Rawls JF. Fxr signaling and microbial metabolism of bile salts in the zebrafish intestine. Sci Adv 2021;7:eabg1371. [PMID: 34301599 DOI: 10.1126/sciadv.abg1371] [Reference Citation Analysis]
92 Chiang JYL, Ferrell JM. Bile Acid Metabolism in Liver Pathobiology. Gene Expr. 2018;18:71-87. [PMID: 29325602 DOI: 10.3727/105221618x15156018385515] [Cited by in Crossref: 103] [Cited by in F6Publishing: 58] [Article Influence: 25.8] [Reference Citation Analysis]
93 Lefebvre P, Staels B. Failing FXR expression in the liver links aging to hepatic steatosis. Journal of Hepatology 2014;60:689-90. [DOI: 10.1016/j.jhep.2014.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
94 Kirichenko TV, Markina YV, Sukhorukov VN, Khotina VA, Wu WK, Orekhov AN. A Novel Insight at Atherogenesis: The Role of Microbiome. Front Cell Dev Biol 2020;8:586189. [PMID: 33072766 DOI: 10.3389/fcell.2020.586189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Li S, Li J, Zhi Z, Hu Y, Ge J, Ye X, Tian D, Linhardt RJ, Chen S. 4-O-Sulfation in sea cucumber fucodians contribute to reversing dyslipidiaemia caused by HFD. International Journal of Biological Macromolecules 2017;99:96-104. [DOI: 10.1016/j.ijbiomac.2017.01.145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
96 Li WC, Zhao SX, Ren WG, Zhang YG, Wang RQ, Kong LB, Zhang QS, Nan YM. Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice. Exp Ther Med 2021;22:830. [PMID: 34149876 DOI: 10.3892/etm.2021.10262] [Reference Citation Analysis]
97 Ridlon JM, Ikegawa S, Alves JM, Zhou B, Kobayashi A, Iida T, Mitamura K, Tanabe G, Serrano M, De Guzman A, Cooper P, Buck GA, Hylemon PB. Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens. J Lipid Res 2013;54:2437-49. [PMID: 23772041 DOI: 10.1194/jlr.M038869] [Cited by in Crossref: 104] [Cited by in F6Publishing: 65] [Article Influence: 11.6] [Reference Citation Analysis]
98 Quintero P, Arrese M. Regulation of bile acid metabolism: New insights from inside: Hepatology. Hepatology 2013;58:1850-3. [DOI: 10.1002/hep.26569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Pierre JF, Martinez KB, Ye H, Nadimpalli A, Morton TC, Yang J, Wang Q, Patno N, Chang EB, Yin DP. Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice. Am J Physiol Gastrointest Liver Physiol 2016;311:G286-304. [PMID: 27340128 DOI: 10.1152/ajpgi.00202.2016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
100 Deckmyn B, Domenger D, Blondel C, Ducastel S, Nicolas E, Dorchies E, Caron E, Charton J, Vallez E, Deprez B, Annicotte J, Lestavel S, Tailleux A, Magnan C, Staels B, Bantubungi K. Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System. Front Mol Neurosci 2022;14:808603. [DOI: 10.3389/fnmol.2021.808603] [Reference Citation Analysis]
101 Golforoush P, Yellon DM, Davidson SM. Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol 2020;115:73. [PMID: 33258000 DOI: 10.1007/s00395-020-00829-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
102 Xu Y. Bile Acid Receptor Modulators in Metabolic Diseases. Elsevier; 2011. pp. 69-87. [DOI: 10.1016/b978-0-12-386009-5.00022-9] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
103 Chen YS, Liu HM, Lee TY. Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice. Cells. 2019;8:253. [PMID: 30884843 DOI: 10.3390/cells8030253] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
104 Murakami S. Role of taurine in the pathogenesis of obesity. Mol Nutr Food Res 2015;59:1353-63. [DOI: 10.1002/mnfr.201500067] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
105 Tokuhara D. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Front Nutr 2021;8:700058. [PMID: 34250000 DOI: 10.3389/fnut.2021.700058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Lai Y, Dhingra R, Zhang Z, Ball LM, Zylka MJ, Lu K. Toward Elucidating the Human Gut Microbiota-Brain Axis: Molecules, Biochemistry, and Implications for Health and Diseases. Biochemistry 2021. [PMID: 34910469 DOI: 10.1021/acs.biochem.1c00656] [Reference Citation Analysis]
107 Kozlowska L, Mizera O, Mroz A. An Untargeted Metabolomics Approach to Investigate the Metabolic Effect of Beetroot Juice Supplementation in Fencers-A Preliminary Study. Metabolites 2020;10:E100. [PMID: 32168803 DOI: 10.3390/metabo10030100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
108 Gilglioni EH, Chang JC, Duijst S, Go S, Adam AAA, Hoekstra R, Verhoeven AJ, Ishii-Iwamoto EL, Oude Elferink RPJ. Improved oxygenation dramatically alters metabolism and gene expression in cultured primary mouse hepatocytes. Hepatol Commun 2018;2:299-312. [PMID: 29507904 DOI: 10.1002/hep4.1140] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
109 Chen M, Penning TM. 5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1). Steroids 2014;83:17-26. [PMID: 24513054 DOI: 10.1016/j.steroids.2014.01.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
110 Di Ciaula A, Garruti G, Wang DQ, Portincasa P. Cholecystectomy and risk of metabolic syndrome. Eur J Intern Med 2018;53:3-11. [PMID: 29706426 DOI: 10.1016/j.ejim.2018.04.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
111 Stinkens R, Goossens GH, Jocken JWE, Blaak EE. Targeting fatty acid metabolism to improve glucose metabolism: Targeting fatty acid metabolism. Obes Rev 2015;16:715-57. [DOI: 10.1111/obr.12298] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 11.3] [Reference Citation Analysis]
112 Lee J, Seok S, Yu P, Kim K, Smith Z, Rivas-Astroza M, Zhong S, Kemper JK. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology. 2012;56:108-117. [PMID: 22278336 DOI: 10.1002/hep.25609] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
113 Boesjes M, Bloks VW, Hageman J, Bos T, van Dijk TH, Havinga R, Wolters H, Jonker JW, Kuipers F, Groen AK. Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in mice. PLoS One 2014;9:e115028. [PMID: 25506828 DOI: 10.1371/journal.pone.0115028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
114 Hua YL, Jia YQ, Zhang XS, Yuan ZW, Ji P, Hu JJ, Wei YM. Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5. Biomed Pharmacother 2021;137:111320. [PMID: 33578232 DOI: 10.1016/j.biopha.2021.111320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Acharya P, Uppin V, Zarei M, Talahalli RR. Role of n-3 Fatty Acids on Bile Acid Metabolism and Transport in Dyslipidemia: A Review. Lipids 2021;56:125-39. [PMID: 33074554 DOI: 10.1002/lipd.12289] [Reference Citation Analysis]
116 Kuosmanen R, Puttreddy R, Willman R, Äijäläinen I, Galandáková A, Ulrichová J, Salo H, Rissanen K, Sievänen E. Biocompatible hydrogelators based on bile acid ethyl amides. Steroids 2016;108:7-16. [DOI: 10.1016/j.steroids.2016.02.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
117 Henkel AS, LeCuyer B, Olivares S, Green RM. Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice. Cell Mol Gastroenterol Hepatol 2017;3:261-71. [PMID: 28275692 DOI: 10.1016/j.jcmgh.2016.11.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
118 Tsuei J, Chau T, Mills D, Wan YJ. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) 2014;239:1489-504. [PMID: 24951470 DOI: 10.1177/1535370214538743] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
119 Lieu T, Jayaweera G, Bunnett NW. GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation. Br J Pharmacol. 2014;171:1156-1166. [PMID: 24111923 DOI: 10.1111/bph.12426] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
120 Berardo C, Di Pasqua LG, Cagna M, Richelmi P, Vairetti M, Ferrigno A. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. Int J Mol Sci 2020;21:E9646. [PMID: 33348908 DOI: 10.3390/ijms21249646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
121 Vanzo A, Scholz M, Gasperotti M, Tramer F, Passamonti S, Vrhovsek U, Mattivi F. Metabonomic investigation of rat tissues following intravenous administration of cyanidin 3-glucoside at a physiologically relevant dose. Metabolomics 2013;9:88-100. [DOI: 10.1007/s11306-012-0430-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
122 Beer LC, Latorre JD, Rochell SJ, Sun X, Tellez G, Fuller AL, Hargis BM, Vuong CN. Research Note: Evaluation of deoxycholic acid for antihistomonal activity. Poult Sci 2020;99:3481-6. [PMID: 32616242 DOI: 10.1016/j.psj.2020.03.049] [Reference Citation Analysis]
123 Pellicciari R, Gioiello A, Sabbatini P, Venturoni F, Nuti R, Colliva C, Rizzo G, Adorini L, Pruzanski M, Roda A, Macchiarulo A. Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators. ACS Med Chem Lett 2012;3:273-7. [PMID: 24900463 DOI: 10.1021/ml200256d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
124 Carr RM, Reid AE. FXR agonists as therapeutic agents for non-alcoholic fatty liver disease. Curr Atheroscler Rep. 2015;17:500. [PMID: 25690590 DOI: 10.1007/s11883-015-0500-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
125 Wang JC, Hill SP, Dilbeck T, Ogunsolu OO, Banerjee T, Hanson K. Multimolecular assemblies on high surface area metal oxides and their role in interfacial energy and electron transfer. Chem Soc Rev 2018;47:104-48. [DOI: 10.1039/c7cs00565b] [Cited by in Crossref: 62] [Cited by in F6Publishing: 2] [Article Influence: 15.5] [Reference Citation Analysis]
126 Lian F, Xing X, Yuan G, Schäfer C, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. Biochem J. 2011;438:315-323. [PMID: 21619550 DOI: 10.1042/bj20102096] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
127 Chevre R, Trigueros-Motos L, Castaño D, Chua T, Corlianò M, Patankar JV, Sng L, Sim L, Juin TL, Carissimo G, Ng LFP, Yi CNJ, Eliathamby CC, Groen AK, Hayden MR, Singaraja RR. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice. FASEB J 2018;32:3792-802. [PMID: 29481310 DOI: 10.1096/fj.201701084RR] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
128 Aw W, Fukuda S. Understanding the role of the gut ecosystem in diabetes mellitus. J Diabetes Investig. 2018;9:5-12. [PMID: 28390093 DOI: 10.1111/jdi.12673] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
129 Shihabudeen MS, Roy D, James J, Thirumurugan K. Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance. Molecular and Cellular Endocrinology 2015;414:19-28. [DOI: 10.1016/j.mce.2015.07.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
130 Zhao WW, Xiao M, Wu X, Li XW, Li XX, Zhao T, Yu L, Chen XQ. Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice. Front Pharmacol 2021;12:771976. [PMID: 34970143 DOI: 10.3389/fphar.2021.771976] [Reference Citation Analysis]
131 Gnocchi D, Ellis ECS, Johansson H, Eriksson M, Bruscalupi G, Steffensen KR, Parini P. Diiodothyronines regulate metabolic homeostasis in primary human hepatocytes by modulating mTORC1 and mTORC2 activity. Mol Cell Endocrinol 2020;499:110604. [PMID: 31580898 DOI: 10.1016/j.mce.2019.110604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T, Zhang T, Wang Y. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis 2018;17:286. [PMID: 30567573 DOI: 10.1186/s12944-018-0939-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 13.8] [Reference Citation Analysis]
133 Yu JH, Zheng JB, Qi J, Yang K, Wu YH, Wang K, Wang CB, Sun XJ. Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway. Int J Oncol 2019;54:879-92. [PMID: 30747230 DOI: 10.3892/ijo.2019.4692] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
134 Armstrong LE, Casa DJ, Belval LN. Metabolism, bioenergetics and thermal physiology: influences of the human intestinal microbiota. Nutr Res Rev 2019;32:205-17. [PMID: 31258100 DOI: 10.1017/S0954422419000076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
135 Tsuchiya T, Naitoh T, Nagao M, Tanaka N, Watanabe K, Imoto H, Miyachi T, Motoi F, Unno M. Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH. Obes Surg 2018;28:1643-52. [PMID: 29235014 DOI: 10.1007/s11695-017-3065-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
136 Seok S, Kanamaluru D, Xiao Z, Ryerson D, Choi SE, Suino-Powell K, Xu HE, Veenstra TD, Kemper JK. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes. J Biol Chem 2013;288:23252-63. [PMID: 23824184 DOI: 10.1074/jbc.M113.452037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
137 Tang WH, Kitai T, Hazen SL. Gut Microbiota in Cardiovascular Health and Disease. Circ Res. 2017;120:1183-1196. [PMID: 28360349 DOI: 10.1161/circresaha.117.309715] [Cited by in Crossref: 516] [Cited by in F6Publishing: 295] [Article Influence: 103.2] [Reference Citation Analysis]
138 Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond). 2013;37:1553-1559. [PMID: 23567924 DOI: 10.1038/ijo.2013.38] [Cited by in Crossref: 110] [Cited by in F6Publishing: 108] [Article Influence: 12.2] [Reference Citation Analysis]
139 Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med 2018;215:383-96. [PMID: 29339445 DOI: 10.1084/jem.20171965] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 31.8] [Reference Citation Analysis]
140 Ong HS, Yim HCH. Microbial Factors in Inflammatory Diseases and Cancers. Adv Exp Med Biol 2017;1024:153-74. [PMID: 28921469 DOI: 10.1007/978-981-10-5987-2_7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
141 Wang P, Zhong H, Song Y, Yuan P, Li Y, Lin S, Zhang X, Li J, Che L, Feng B, Lin Y, Xu S, Zhuo Y, Tian G, Chen D, Wu, Burrin DG, Fang Z. Targeted metabolomics analysis of maternal-placental-fetal metabolism in pregnant swine reveals links in fetal bile acid homeostasis and sulfation capacity. Am J Physiol Gastrointest Liver Physiol 2019;317:G8-G16. [PMID: 31021171 DOI: 10.1152/ajpgi.00056.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
142 Perreault M, Białek A, Trottier J, Verreault M, Caron P, Milkiewicz P, Barbier O. Role of glucuronidation for hepatic detoxification and urinary elimination of toxic bile acids during biliary obstruction. PLoS One 2013;8:e80994. [PMID: 24244729 DOI: 10.1371/journal.pone.0080994] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
143 Wollam J, Magner DB, Magomedova L, Rass E, Shen Y, Rottiers V, Habermann B, Cummins CL, Antebi A. A novel 3-hydroxysteroid dehydrogenase that regulates reproductive development and longevity. PLoS Biol 2012;10:e1001305. [PMID: 22505847 DOI: 10.1371/journal.pbio.1001305] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
144 Liu JL, Hekimi S. The impact of mitochondrial oxidative stress on bile acid-like molecules in C. elegans provides a new perspective on human metabolic diseases. Worm 2013;2:e21457. [PMID: 24058856 DOI: 10.4161/worm.21457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
145 Newsholme P, Fiamoncini J, Curi R, Daniel H. Metabolism of bile acids in the post-prandial state. Essays in Biochemistry 2016;60:409-18. [DOI: 10.1042/ebc20160052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
146 Blaschka C, Sánchez-Guijo A, Wudy SA, Wrenzycki C. Profile of bile acid subspecies is similar in blood and follicular fluid of cattle. Vet Med Sci 2020;6:167-76. [PMID: 31713347 DOI: 10.1002/vms3.217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Song Q, Wang Y, Huang L, Shen M, Yu Y, Yu Q, Chen Y, Xie J. Review of the relationships among polysaccharides, gut microbiota, and human health. Food Research International 2021;140:109858. [DOI: 10.1016/j.foodres.2020.109858] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
148 Blazquez M, Carretero A, Ellis JK, Athersuch TJ, Cavill R, Ebbels TM, Keun HC, Castell JV, Lahoz A, Bort R. A combination of transcriptomics and metabolomics uncovers enhanced bile acid biosynthesis in HepG2 cells expressing CCAAT/enhancer-binding protein β (C/EBPβ), hepatocyte nuclear factor 4α (HNF4α), and constitutive androstane receptor (CAR). J Proteome Res 2013;12:2732-41. [PMID: 23641669 DOI: 10.1021/pr400085n] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
149 Jergens AE, Guard BC, Redfern A, Rossi G, Mochel JP, Pilla R, Chandra L, Seo YJ, Steiner JM, Lidbury J, Allenspach K, Suchodolski J. Microbiota-Related Changes in Unconjugated Fecal Bile Acids Are Associated With Naturally Occurring, Insulin-Dependent Diabetes Mellitus in Dogs. Front Vet Sci 2019;6:199. [PMID: 31316997 DOI: 10.3389/fvets.2019.00199] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
150 Achenbach J, Gabler M, Steri R, Schubert-zsilavecz M, Proschak E. Identification of novel farnesoid X receptor modulators using a combined ligand- and structure-based virtual screening. Med Chem Commun 2013;4:920. [DOI: 10.1039/c3md00049d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
151 Evans MJ, Gardell SJ. Farnesoid X receptor as a therapeutic target for dyslipidemia. Clinical Lipidology 2009;4:587-94. [DOI: 10.2217/clp.09.51] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
152 Villette R, Kc P, Beliard S, Salas Tapia MF, Rainteau D, Guerin M, Lesnik P. Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol Levels. Front Pharmacol 2020;11:278. [PMID: 32308619 DOI: 10.3389/fphar.2020.00278] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
153 Miyachi T, Nagao M, Shibata C, Kitahara Y, Tanaka N, Watanabe K, Tsuchiya T, Motoi F, Naitoh T, Unno M. Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes. Surgery 2016;159:1360-71. [PMID: 26767308 DOI: 10.1016/j.surg.2015.11.027] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
154 Paternoster S, Falasca M. Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1. Front Endocrinol (Lausanne) 2018;9:584. [PMID: 30364192 DOI: 10.3389/fendo.2018.00584] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
155 Renga B, Mencarelli A, D'Amore C, Cipriani S, Baldelli F, Zampella A, Distrutti E, Fiorucci S. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. FASEB J 2012;26:3021-31. [PMID: 22447981 DOI: 10.1096/fj.11-195701] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
156 Ku BJ, Kim TH, Lee JH, Buras ED, White LD, Stevens RD, Ilkayeva OR, Bain JR, Newgard CB, DeMayo FJ, Jeong JW. Mig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis. PLoS One 2012;7:e42915. [PMID: 22912762 DOI: 10.1371/journal.pone.0042915] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
157 Pai R, French D, Ma N, Hotzel K, Plise E, Salphati L, Setchell KD, Ware J, Lauriault V, Schutt L, Hartley D, Dambach D. Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys. Toxicol Sci 2012;126:446-56. [PMID: 22268002 DOI: 10.1093/toxsci/kfs011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
158 Ding L, Zhang L, Shi H, Xue C, Yanagita T, Zhang T, Wang Y. The Protective Effect of Dietary EPA‐Enriched Ethanolamine Plasmalogens against Hyperlipidemia in Aged Mice. Eur J Lipid Sci Technol 2020;122:2000179. [DOI: 10.1002/ejlt.202000179] [Reference Citation Analysis]
159 Garvey WT. Is Obesity/Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second Generation Medications. Endocr Pract 2021:S1530-891X(21)01380-X. [PMID: 34823000 DOI: 10.1016/j.eprac.2021.11.082] [Reference Citation Analysis]
160 Skelly AN, Sato Y, Kearney S, Honda K. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 2019;19:305-23. [DOI: 10.1038/s41577-019-0144-5] [Cited by in Crossref: 106] [Cited by in F6Publishing: 83] [Article Influence: 35.3] [Reference Citation Analysis]
161 Ambolet-Camoit A, Ottolenghi C, Leblanc A, Kim MJ, Letourneur F, Jacques S, Cagnard N, Guguen-Guillouzo C, Barouki R, Aggerbeck M. Two persistent organic pollutants which act through different xenosensors (alpha-endosulfan and 2,3,7,8 tetrachlorodibenzo-p-dioxin) interact in a mixture and downregulate multiple genes involved in human hepatocyte lipid and glucose metabolism. Biochimie 2015;116:79-91. [PMID: 26159488 DOI: 10.1016/j.biochi.2015.07.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
162 Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, Zhang Y, Lei S, Wang S, Kuang J, Han X, Wei M, You Y, Li M, Li Y, Liang D, Liu J, Chen T, Yan C, Wei R, Rajani C, Shen C, Xie G, Bian Z, Li H, Zhao A, Jia W. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun 2019;10:4971. [PMID: 31672964 DOI: 10.1038/s41467-019-12896-x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 27.7] [Reference Citation Analysis]
163 Dubois-Chevalier J, Dubois V, Dehondt H, Mazrooei P, Mazuy C, Sérandour AA, Gheeraert C, Guillaume P, Baugé E, Derudas B, Hennuyer N, Paumelle R, Marot G, Carroll JS, Lupien M, Staels B, Lefebvre P, Eeckhoute J. The logic of transcriptional regulator recruitment architecture at cis-regulatory modules controlling liver functions. Genome Res 2017;27:985-96. [PMID: 28400425 DOI: 10.1101/gr.217075.116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
164 Eggink HM, Tambyrajah LL, van den Berg R, Mol IM, van den Heuvel JK, Koehorst M, Groen AK, Boelen A, Kalsbeek A, Romijn JA, Rensen PCN, Kooijman S, Soeters MR. Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice. J Endocrinol 2018;236:85-97. [PMID: 29233934 DOI: 10.1530/JOE-17-0503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
165 Lau LHS, Wong SH. Microbiota, Obesity and NAFLD. Adv Exp Med Biol. 2018;1061:111-125. [PMID: 29956210 DOI: 10.1007/978-981-10-8684-7_9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
166 Lukashev NV, Grabovyi GA, Erzunov DA, Kazantsev AV, Latyshev GV, Averin AD, Beletskaya IP. Pd- and Cu-catalyzed approaches in the syntheses of new cholane aminoanthraquinone pincer-like ligands. Beilstein J Org Chem 2017;13:564-70. [PMID: 28405236 DOI: 10.3762/bjoc.13.55] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
167 Hoogerland JA, Lei Y, Wolters JC, de Boer JF, Bos T, Bleeker A, Mulder NL, van Dijk TH, Kuivenhoven JA, Rajas F, Mithieux G, Haeusler RA, Verkade HJ, Bloks VW, Kuipers F, Oosterveer MH. Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice. Hepatology 2019;70:2171-84. [PMID: 31102537 DOI: 10.1002/hep.30778] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
168 de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657-669. [PMID: 23602448 DOI: 10.1016/j.cmet.2013.03.013] [Cited by in Crossref: 478] [Cited by in F6Publishing: 439] [Article Influence: 53.1] [Reference Citation Analysis]
169 Lazaridis N, Tsochatzis E. Current and future treatment options in non-alcoholic steatohepatitis (NASH). Expert Review of Gastroenterology & Hepatology 2017;11:357-69. [DOI: 10.1080/17474124.2017.1293523] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
170 Bahne E, Hansen M, Brønden A, Sonne DP, Vilsbøll T, Knop FK. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin. Diabetes Obes Metab 2016;18:955-61. [DOI: 10.1111/dom.12697] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
171 Wahlström A, Sayin S, Marschall H, Bäckhed F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell Metabolism 2016;24:41-50. [DOI: 10.1016/j.cmet.2016.05.005] [Cited by in Crossref: 820] [Cited by in F6Publishing: 740] [Article Influence: 136.7] [Reference Citation Analysis]
172 Al-Khaifi A, Straniero S, Voronova V, Chernikova D, Sokolov V, Kumar C, Angelin B, Rudling M. Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism. J Intern Med 2018;284:546-59. [PMID: 29964306 DOI: 10.1111/joim.12811] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
173 Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW, Corvera CU. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 2013;144:145-54. [PMID: 23041323 DOI: 10.1053/j.gastro.2012.09.055] [Cited by in Crossref: 159] [Cited by in F6Publishing: 155] [Article Influence: 15.9] [Reference Citation Analysis]
174 Morton GJ, Kaiyala KJ, Foster-Schubert KE, Cummings DE, Schwartz MW. Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans. J Clin Endocrinol Metab 2014;99:E241-5. [PMID: 24297792 DOI: 10.1210/jc.2013-3129] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
175 Kuipers F, Groen AK. FXR: the key to benefits in bariatric surgery? Nat Med. 2014;20:337-338. [PMID: 24710375 DOI: 10.1038/nm.3525] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
176 Huang XF, Zhao WY, Huang WD. FXR and liver carcinogenesis. Acta Pharmacol Sin 2015;36:37-43. [PMID: 25500874 DOI: 10.1038/aps.2014.117] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
177 Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology 2013; 145: 574-82. e1. [PMID: 23727264 DOI: 10.1053/j.gastro.2013.05.042] [Cited by in Crossref: 534] [Cited by in F6Publishing: 506] [Article Influence: 59.3] [Reference Citation Analysis]
178 Kroll T, Prescher M, Smits SHJ, Schmitt L. Structure and Function of Hepatobiliary ATP Binding Cassette Transporters. Chem Rev 2021;121:5240-88. [PMID: 33201677 DOI: 10.1021/acs.chemrev.0c00659] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
179 Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD/NASH. Front Biosci (Landmark Ed) 2021;26:206-37. [PMID: 33049668 DOI: 10.2741/4892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
180 Eggink HM, van Nierop FS, Schooneman MG, Boelen A, Kalsbeek A, Koehorst M, ten Have GA, de Brauw LM, Groen AK, Romijn JA, Deutz NE, Soeters MR. Transhepatic bile acid kinetics in pigs and humans. Clinical Nutrition 2018;37:1406-14. [DOI: 10.1016/j.clnu.2017.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
181 Zhou X, Cao L, Jiang C, Xie Y, Cheng X, Krausz KW, Qi Y, Sun L, Shah YM, Gonzalez FJ, Wang G, Hao H. PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis. Nat Commun 2014;5:4573. [PMID: 25183423 DOI: 10.1038/ncomms5573] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 9.8] [Reference Citation Analysis]
182 Vignozzi L, Morelli A, Filippi S, Comeglio P, Chavalmane AK, Marchetta M, Toce M, Yehiely-Cohen R, Vannelli GB, Adorini L. Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes. J Sex Med. 2011;8:57-77. [PMID: 20955313 DOI: 10.1111/j.1743-6109.2010.02073.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
183 Létourneau D, Lorin A, Lefebvre A, Cabana J, Lavigne P, LeHoux JG. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5. Biochim Biophys Acta 2013;1831:1589-99. [PMID: 23872533 DOI: 10.1016/j.bbalip.2013.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
184 Noguchi H, Yamada S, Nabeshima A, Guo X, Tanimoto A, Wang KY, Kitada S, Tasaki T, Takama T, Shimajiri S, Horlad H, Komohara Y, Izumi H, Kohno K, Ichijo H, Sasaguri Y. Depletion of apoptosis signal-regulating kinase 1 prevents bile duct ligation-induced necroinflammation and subsequent peribiliary fibrosis. Am J Pathol 2014;184:644-61. [PMID: 24412091 DOI: 10.1016/j.ajpath.2013.11.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
185 Fu ZD, Klaassen CD. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice. Toxicol Appl Pharmacol 2013;273:680-90. [PMID: 24183703 DOI: 10.1016/j.taap.2013.10.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
186 Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Yamauchi N, Ushiku T, Moriya K, Yotsuyanagi H, Koike K. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet. PLoS One 2020;15:e0234750. [PMID: 32785220 DOI: 10.1371/journal.pone.0234750] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Gertzen CGW, Gohlke H, Häussinger D, Herebian D, Keitel V, Kubitz R, Mayatepek E, Schmitt L. The many facets of bile acids in the physiology and pathophysiology of the human liver. Biol Chem 2021;402:1047-62. [PMID: 34049433 DOI: 10.1515/hsz-2021-0156] [Reference Citation Analysis]
188 Zhang J, Liang S, Ning R, Jiang J, Zhang J, Shen H, Chen R, Duan J, Sun Z. PM2.5-induced inflammation and lipidome alteration associated with the development of atherosclerosis based on a targeted lipidomic analysis. Environment International 2020;136:105444. [DOI: 10.1016/j.envint.2019.105444] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
189 Fairweather SJ, Shah N, Brӧer S. Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology. Adv Exp Med Biol 2021;21:13-127. [PMID: 33052588 DOI: 10.1007/5584_2020_584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
190 Dixon JB, Lambert EA, Lambert GW. Neuroendocrine adaptations to bariatric surgery. Mol Cell Endocrinol 2015;418 Pt 2:143-52. [PMID: 26044866 DOI: 10.1016/j.mce.2015.05.033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
191 Scherer M, Gnewuch C, Schmitz G, Liebisch G. Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3920-3925. [PMID: 19819765 DOI: 10.1016/j.jchromb.2009.09.038] [Cited by in Crossref: 145] [Cited by in F6Publishing: 132] [Article Influence: 11.2] [Reference Citation Analysis]
192 Somm E, Jornayvaz FR. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives. Endocr Rev 2018;39:960-89. [PMID: 30124818 DOI: 10.1210/er.2018-00134] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
193 Fang W, Wen X, Meng Q, Wu W, Everaert N, Xie J, Zhang H. Alteration in bile acids profile in Large White pigs during chronic heat exposure. J Therm Biol 2019;84:375-83. [PMID: 31466777 DOI: 10.1016/j.jtherbio.2019.07.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
194 Mikkelsen KH, Allin KH, Knop FK. Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature. Diabetes Obes Metab. 2016;18:444-453. [PMID: 26818734 DOI: 10.1111/dom.12637] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
195 Mencarelli A, Renga B, D'Amore C, Santorelli C, Graziosi L, Bruno A, Monti MC, Distrutti E, Cipriani S, Donini A, Fiorucci S. Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. Diabetes 2013;62:3384-93. [PMID: 23835330 DOI: 10.2337/db13-0299] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
196 Luu TH, Bard JM, Carbonnelle D, Chaillou C, Huvelin JM, Bobin-Dubigeon C, Nazih H. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells. Cell Oncol (Dordr) 2018;41:13-24. [PMID: 28993998 DOI: 10.1007/s13402-017-0353-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
197 Kazgan N, Metukuri MR, Purushotham A, Lu J, Rao A, Lee S, Pratt-Hyatt M, Lickteig A, Csanaky IL, Zhao Y, Dawson PA, Li X. Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1α-FXR signaling and alters systemic bile acid homeostasis. Gastroenterology 2014;146:1006-16. [PMID: 24389307 DOI: 10.1053/j.gastro.2013.12.029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
198 Du Y, Chen H, Xuan Z, Song W, Hong L, Guo D, Li H, Tuo B, Zheng S, Song P. Bile deficiency induces changes in intestinal glucose absorption in mice. Surgery 2016;160:1496-507. [PMID: 27495848 DOI: 10.1016/j.surg.2016.05.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
199 Egresi A, Lengyel G, Hagymási K. [Non-invasive assessment of fatty liver]. Orv Hetil 2015;156:543-51. [PMID: 25819147 DOI: 10.1556/OH.2015.30123] [Reference Citation Analysis]
200 Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R. Role of gut microbiota in cardiovascular diseases. World J Cardiol 2020; 12(4): 110-122 [PMID: 32431782 DOI: 10.4330/wjc.v12.i4.110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
201 Yap TW, Leow AH, Azmi AN, Callahan DL, Perez-Perez GI, Loke MF, Goh KL, Vadivelu J. Global Fecal and Plasma Metabolic Dynamics Related to Helicobacter pylori Eradication. Front Microbiol 2017;8:536. [PMID: 28424674 DOI: 10.3389/fmicb.2017.00536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
202 Lin S, Teng L, Lin Y, Miao L, Ge X, Hao J, Huang X, Liu B. Molecular and functional characterization of sirt4 and sirt6 in Megalobrama amblycephala under high glucose metabolism. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2019;231:87-97. [DOI: 10.1016/j.cbpb.2019.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
203 Mazidi M, Rezaie P, Karimi E, Kengne AP. The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials. International Journal of Cardiology 2017;227:850-7. [DOI: 10.1016/j.ijcard.2016.10.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
204 Kim JH, Meyers MS, Khuder SS, Abdallah SL, Muturi HT, Russo L, Tate CR, Hevener AL, Najjar SM, Leloup C, Mauvais-Jarvis F. Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. Mol Metab 2014;3:177-90. [PMID: 24634829 DOI: 10.1016/j.molmet.2013.12.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 8.9] [Reference Citation Analysis]
205 Fonseca VA, Handelsman Y, Staels B. Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence. Diabetes Obes Metab 2010;12:384-92. [PMID: 20415686 DOI: 10.1111/j.1463-1326.2009.01181.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
206 Glastras SJ, Wong MG, Chen H, Zhang J, Zaky A, Pollock CA, Saad S. FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity. Nutr Metab (Lond) 2015;12:40. [PMID: 26583035 DOI: 10.1186/s12986-015-0032-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
207 Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Käkelä P, Pääkkönen M, Hallikainen M, Kolehmainen M, Uusitupa M, Moilanen L. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg. 2012;22:1473-1480. [PMID: 22638681 DOI: 10.1007/s11695-012-0673-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 12.2] [Reference Citation Analysis]
208 Serviddio G, Bellanti F, Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic Biol Med. 2013;65:952-968. [PMID: 23994574 DOI: 10.1016/j.freeradbiomed.2013.08.174] [Cited by in Crossref: 133] [Cited by in F6Publishing: 120] [Article Influence: 14.8] [Reference Citation Analysis]
209 Bays HE. Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus. Int J Gen Med 2014;7:355-64. [PMID: 25045281 DOI: 10.2147/IJGM.S65148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
210 Singh N, Bhattacharyya D. Identification of the anti-oxidant components in a two-step solvent extract of bovine bile lipid: Application of reverse phase HPLC, mass spectrometry and fluorimetric assays. Journal of Chromatography B 2016;1019:83-94. [DOI: 10.1016/j.jchromb.2015.11.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Gomez-Perez A, Kyryakov P, Burstein MT, Asbah N, Noohi F, Iouk T, Titorenko VI. Empirical Validation of a Hypothesis of the Hormetic Selective Forces Driving the Evolution of Longevity Regulation Mechanisms. Front Genet 2016;7:216. [PMID: 27999589 DOI: 10.3389/fgene.2016.00216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
212 Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, Zhang Y, Fan H, Zheng L, Liu Z, Zhou X. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis. Obes Rev 2019;20:883-94. [PMID: 30868721 DOI: 10.1111/obr.12843] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
213 Hild B, Heinzow HS, Schmidt HH, Maschmeier M. Bile Acids in Control of the Gut-Liver-Axis. Z Gastroenterol 2021;59:63-8. [PMID: 33429452 DOI: 10.1055/a-1330-9644] [Reference Citation Analysis]
214 Roth JD, Feigh M, Veidal SS, Fensholdt LK, Rigbolt KT, Hansen HH, Chen LC, Petitjean M, Friley W, Vrang N, Jelsing J, Young M. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World J Gastroenterol 2018; 24(2): 195-210 [PMID: 29375205 DOI: 10.3748/wjg.v24.i2.195] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
215 Corteville C, Fassnacht M, Bueter M. [Surgery as pluripotent instrument for metabolic disease. What are the mechanisms?]. Chirurg 2014;85:963-8. [PMID: 25312490 DOI: 10.1007/s00104-014-2796-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
216 Baars A, Oosting A, Knol J, Garssen J, van Bergenhenegouwen J. The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5. Microorganisms 2015;3:641-66. [PMID: 27682110 DOI: 10.3390/microorganisms3040641] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
217 Gordon JI, Dewey KG, Mills DA, Medzhitov RM. The human gut microbiota and undernutrition. Sci Transl Med 2012;4:137ps12. [PMID: 22674549 DOI: 10.1126/scitranslmed.3004347] [Cited by in Crossref: 117] [Cited by in F6Publishing: 107] [Article Influence: 11.7] [Reference Citation Analysis]
218 Sangaraju D, Shi Y, Van Parys M, Ray A, Walker A, Caminiti R, Milanowski D, Jaochico A, Dean B, Liang X. Robust and Comprehensive Targeted Metabolomics Method for Quantification of 50 Different Primary, Secondary, and Sulfated Bile Acids in Multiple Biological Species (Human, Monkey, Rabbit, Dog, and Rat) and Matrices (Plasma and Urine) Using Liquid Chromatography High Resolution Mass Spectrometry (LC-HRMS) Analysis. J Am Soc Mass Spectrom 2021;32:2033-49. [PMID: 33826317 DOI: 10.1021/jasms.0c00435] [Reference Citation Analysis]
219 Yamada S, Kawaguchi H, Yamada T, Guo X, Matsuo K, Hamada T, Miura N, Tasaki T, Tanimoto A. Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs. J Atheroscler Thromb 2017;24:1150-66. [PMID: 28496045 DOI: 10.5551/jat.39909] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
220 Zhou J, Tang L, Wang J, Wang J. Aflatoxin B1 Disrupts Gut-Microbial Metabolisms of Short-Chain Fatty Acids, Long-Chain Fatty Acids, and Bile Acids in Male F344 Rats. Toxicological Sciences 2018;164:453-64. [DOI: 10.1093/toxsci/kfy102] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
221 Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol 2014;592:2943-50. [PMID: 24614746 DOI: 10.1113/jphysiol.2014.271155] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
222 Chávez-talavera O, Wargny M, Pichelin M, Descat A, Vallez E, Kouach M, Bigot-corbel E, Joliveau M, Goossens J, Le May C, Hadjadj S, Hanf R, Tailleux A, Staels B, Cariou B. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes. Metabolism 2020;103:154042. [DOI: 10.1016/j.metabol.2019.154042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
223 Ducastel S, Touche V, Trabelsi MS, Boulinguiez A, Butruille L, Nawrot M, Peschard S, Chávez-Talavera O, Dorchies E, Vallez E, Annicotte JS, Lancel S, Briand O, Bantubungi K, Caron S, Bindels LB, Delzenne NM, Tailleux A, Staels B, Lestavel S. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids. Sci Rep 2020;10:174. [PMID: 31932631 DOI: 10.1038/s41598-019-56743-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
224 Ning Y, Xu L, Ren S, Pandak WM, Chen S, Yin L. StAR overexpression decreases serum and tissue lipids in apolipoprotein E-deficient mice. Lipids. 2009;44:511-519. [PMID: 19373502 DOI: 10.1007/s11745-009-3299-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
225 Sharanek A, Burban A, Humbert L, Guguen-guillouzo C, Rainteau D, Guillouzo A. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation. Drug Metab Dispos 2017;45:1292-303. [DOI: 10.1124/dmd.117.077420] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
226 McGavigan AK, Garibay D, Henseler ZM, Chen J, Bettaieb A, Haj FG, Ley RE, Chouinard ML, Cummings BP. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice. Gut. 2017;66:226-234. [PMID: 26511794 DOI: 10.1136/gutjnl-2015-309871] [Cited by in Crossref: 120] [Cited by in F6Publishing: 115] [Article Influence: 17.1] [Reference Citation Analysis]
227 Arrese M, Cortés V, Barrera F, Nervi F. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship. Curr Opin Gastroenterol 2018;34:90-6. [PMID: 29266009 DOI: 10.1097/MOG.0000000000000416] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
228 Goldberg AA, Kyryakov P, Bourque SD, Titorenko VI. Xenohormetic, hormetic and cytostatic selective forces driving longevity at the ecosystemic level. Aging (Albany NY) 2010;2:461-70. [PMID: 20693605 DOI: 10.18632/aging.100186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
229 Shen Y, Shi S, Tong H, Guo Y, Zou J. Metabolomics analysis reveals that bile acids and phospholipids contribute to variable responses to low-temperature-induced ascites syndrome. Mol BioSyst 2014;10:1557-67. [DOI: 10.1039/c4mb00137k] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
230 Verbeke L, Farre R, Verbinnen B, Covens K, Vanuytsel T, Verhaegen J, Komuta M, Roskams T, Chatterjee S, Annaert P, Elst IV, Windmolders P, Trebicka J, Nevens F, Laleman W. The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats. Am J Pathol. 2015;185:409-419. [PMID: 25592258 DOI: 10.1016/j.ajpath.2014.10.009] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 14.4] [Reference Citation Analysis]
231 Vyas U, Ranganathan N. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract 2012;2012:872716. [PMID: 23049548 DOI: 10.1155/2012/872716] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 8.5] [Reference Citation Analysis]
232 Zheng J, Ye C, Hu B, Yang H, Yao Q, Ma J, Liu Y, Liu H. Bile acid profiles in bile and feces of obese mice by a high-performance liquid chromatography-tandem mass spectrometry. Biotechnol Appl Biochem 2020. [PMID: 33140486 DOI: 10.1002/bab.2055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
233 Yan J, Xie G, Liang C, Hu Y, Zhao A, Huang F, Hu P, Liu P, Jia W, Wang X. Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats. Sci Rep 2017;7:4211. [PMID: 28646179 DOI: 10.1038/s41598-017-04536-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
234 Levi M. Role of Bile Acid-Regulated Nuclear Receptor FXR and G Protein-Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease). Hypertension 2016;67:1080-4. [PMID: 27045028 DOI: 10.1161/HYPERTENSIONAHA.115.06417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
235 Moustafa T, Fickert P, Magnes C, Guelly C, Thueringer A, Frank S, Kratky D, Sattler W, Reicher H, Sinner F, Gumhold J, Silbert D, Fauler G, Höfler G, Lass A, Zechner R, Trauner M. Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury. Gastroenterology 2012;142:140-151.e12. [DOI: 10.1053/j.gastro.2011.09.051] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 9.9] [Reference Citation Analysis]
236 Nagy RA, van Montfoort AP, Dikkers A, van Echten-Arends J, Homminga I, Land JA, Hoek A, Tietge UJ. Presence of bile acids in human follicular fluid and their relation with embryo development in modified natural cycle IVF. Hum Reprod 2015;30:1102-9. [PMID: 25753582 DOI: 10.1093/humrep/dev034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
237 Lassailly G, Caiazzo R, Pattou F, Mathurin P. Perspectives on Treatment for Nonalcoholic Steatohepatitis. Gastroenterology. 2016;150:1835-1848. [PMID: 26971824 DOI: 10.1053/j.gastro.2016.03.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
238 Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, Elst IV, Windmolders P, Vanuytsel T, Nevens F. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology. 2014;59:2286-2298. [PMID: 24259407 DOI: 10.1002/hep.26939] [Cited by in Crossref: 153] [Cited by in F6Publishing: 151] [Article Influence: 19.1] [Reference Citation Analysis]
239 Sonne DP, Hansen M, Knop FK. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion. Eur J Endocrinol. 2014;171:R47-R65. [PMID: 24760535 DOI: 10.1530/eje-14-0154] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
240 Hodson L, Fielding BA. Trafficking and partitioning of fatty acids: the transition from fasted to fed state. Clinical Lipidology 2010;5:131-44. [DOI: 10.2217/clp.09.72] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
241 Uno S, Nebert DW, Makishima M. Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice. Food Chem Toxicol 2018;113:73-82. [PMID: 29366871 DOI: 10.1016/j.fct.2018.01.029] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
242 Muthusamy S, Malhotra P, Hosameddin M, Dudeja AK, Borthakur S, Saksena S, Gill RK, Dudeja PK, Alrefai WA. N-glycosylation is essential for ileal ASBT function and protection against proteases. Am J Physiol Cell Physiol 2015;308:C964-71. [PMID: 25855079 DOI: 10.1152/ajpcell.00023.2015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
243 Kong M, Lu Z, Zhong C, Gao Q, Zhou X, Chen R, Xiong G, Hao L, Yang X, Yang N. A higher level of total bile acid in early mid-pregnancy is associated with an increased risk of gestational diabetes mellitus: a prospective cohort study in Wuhan, China. J Endocrinol Invest 2020;43:1097-103. [PMID: 32086784 DOI: 10.1007/s40618-020-01196-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
244 Tran CD, Grice DM, Wade B, Kerr CA, Bauer DC, Li D, Hannan GN. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. Future Microbiology 2015;10:1339-53. [DOI: 10.2217/fmb.15.54] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
245 Li T, Francl JM, Boehme S, Chiang JY. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. Hepatology 2013;58:1111-21. [PMID: 23536474 DOI: 10.1002/hep.26427] [Cited by in Crossref: 93] [Cited by in F6Publishing: 90] [Article Influence: 10.3] [Reference Citation Analysis]
246 Bell DS. Changes seen in gut bacteria content and distribution with obesity: causation or association? Postgrad Med 2015;127:863-8. [PMID: 26474235 DOI: 10.1080/00325481.2015.1098519] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
247 Steiner C, von Eckardstein A, Rentsch KM. Quantification of the 15 major human bile acids and their precursor 7α-hydroxy-4-cholesten-3-one in serum by liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 2010;878:2870-80. [DOI: 10.1016/j.jchromb.2010.08.045] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
248 Giusti V, Theytaz F, Di Vetta V, Clarisse M, Suter M, Tappy L. Energy and macronutrient intake after gastric bypass for morbid obesity: a 3-y observational study focused on protein consumption. The American Journal of Clinical Nutrition 2016;103:18-24. [DOI: 10.3945/ajcn.115.111732] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
249 Albaugh VL, Flynn CR, Tamboli RA, Abumrad NN. Recent advances in metabolic and bariatric surgery. F1000Res 2016;5:F1000 Faculty Rev-978. [PMID: 27239296 DOI: 10.12688/f1000research.7240.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
250 Ballatori N, Christian WV, Wheeler SG, Hammond CL. The heteromeric organic solute transporter, OSTα-OSTβ/SLC51: a transporter for steroid-derived molecules. Mol Aspects Med 2013;34:683-92. [PMID: 23506901 DOI: 10.1016/j.mam.2012.11.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
251 Respondek F, Gerard P, Bossis M, Boschat L, Bruneau A, Rabot S, Wagner A, Martin JC. Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS One 2013;8:e71026. [PMID: 23951074 DOI: 10.1371/journal.pone.0071026] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
252 Vincent RP, Omar S, Ghozlan S, Taylor DR, Cross G, Sherwood RA, Fandriks L, Olbers T, Werling M, Alaghband-Zadeh J, le Roux CW. Higher circulating bile acid concentrations in obese patients with type 2 diabetes. Ann Clin Biochem 2013;50:360-4. [PMID: 23771134 DOI: 10.1177/0004563212473450] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
253 Nie YF, Hu J, Yan XH. Cross-talk between bile acids and intestinal microbiota in host metabolism and health. J Zhejiang Univ Sci B. 2015;16:436-446. [PMID: 26055905 DOI: 10.1631/jzus.b1400327] [Cited by in Crossref: 62] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
254 Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids. Diabetes. 2013;62:4184-4191. [PMID: 23884887 DOI: 10.2337/db13-0639] [Cited by in Crossref: 225] [Cited by in F6Publishing: 218] [Article Influence: 25.0] [Reference Citation Analysis]
255 Liu L, Liu Z, Li H, Cao Z, Li W, Song Z, Li X, Lu A, Lu C, Liu Y. Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis. Front Pharmacol 2020;11:12. [PMID: 32116693 DOI: 10.3389/fphar.2020.00012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
256 Blesl A, Stadlbauer V. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021;13:1018. [PMID: 33801133 DOI: 10.3390/nu13031018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Martin LJ, Tremblay JJ. Nuclear receptors in Leydig cell gene expression and function. Biol Reprod 2010;83:3-14. [PMID: 20375256 DOI: 10.1095/biolreprod.110.083824] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
258 Appleby RN, Walters JR. The role of bile acids in functional GI disorders. Neurogastroenterol Motil. 2014;26:1057-1069. [PMID: 24898156 DOI: 10.1111/nmo.12370] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
259 Chen ML, Sundrud MS. Xenobiotic and endobiotic handling by the mucosal immune system. Curr Opin Gastroenterol 2018;34:404-12. [PMID: 30299289 DOI: 10.1097/MOG.0000000000000478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
260 Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corno C, Adorini L, Vannelli GB, Maggi M, Vignozzi L. Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. J Endocrinol Invest 2019;42:951-65. [PMID: 30674010 DOI: 10.1007/s40618-019-1009-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
261 Vallim TQ, Edwards PA. Bile acids have the gall to function as hormones. Cell Metab 2009;10:162-4. [PMID: 19723491 DOI: 10.1016/j.cmet.2009.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
262 Liu X, Zheng H, Lu R, Huang H, Zhu H, Yin C, Mo Y, Wu J, Liu X, Deng M, Li D, Cheng B, Wu F, Liang Y, Guo H, Song H, Su Z. Intervening Effects of Total Alkaloids of Corydalis saxicola Bunting on Rats With Antibiotic-Induced Gut Microbiota Dysbiosis Based on 16S rRNA Gene Sequencing and Untargeted Metabolomics Analyses. Front Microbiol 2019;10:1151. [PMID: 31214133 DOI: 10.3389/fmicb.2019.01151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
263 Trauner M, Baghdasaryan A, Claudel T, Fickert P, Halilbasic E, Moustafa T, Zollner G. Targeting nuclear bile acid receptors for liver disease. Dig Dis. 2011;29:98-102. [PMID: 21691114 DOI: 10.1159/000324141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
264 Zollner G, Wagner M, Trauner M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol Ther 2010;126:228-43. [PMID: 20388526 DOI: 10.1016/j.pharmthera.2010.03.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
265 Ramírez-jiménez AK, Reynoso-camacho R, Tejero ME, León-galván F, Loarca-piña G. Potential role of bioactive compounds of Phaseolus vulgaris L. on lipid-lowering mechanisms. Food Research International 2015;76:92-104. [DOI: 10.1016/j.foodres.2015.01.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
266 Ferrigno A, Di Pasqua LG, Berardo C, Siciliano V, Rizzo V, Adorini L, Richelmi P, Vairetti M. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury. PLoS One 2018;13:e0191430. [PMID: 29346429 DOI: 10.1371/journal.pone.0191430] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
267 Demetz E, Schroll A, Auer K, Heim C, Patsch JR, Eller P, Theurl M, Theurl I, Theurl M, Seifert M, Lener D, Stanzl U, Haschka D, Asshoff M, Dichtl S, Nairz M, Huber E, Stadlinger M, Moschen AR, Li X, Pallweber P, Scharnagl H, Stojakovic T, März W, Kleber ME, Garlaschelli K, Uboldi P, Catapano AL, Stellaard F, Rudling M, Kuba K, Imai Y, Arita M, Schuetz JD, Pramstaller PP, Tietge UJF, Trauner M, Norata GD, Claudel T, Hicks AA, Weiss G, Tancevski I. The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab 2014;20:787-98. [PMID: 25444678 DOI: 10.1016/j.cmet.2014.09.004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 9.1] [Reference Citation Analysis]
268 Fiamoncini J, Yiorkas AM, Gedrich K, Rundle M, Alsters SI, Roeselers G, van den Broek TJ, Clavel T, Lagkouvardos I, Wopereis S, Frost G, van Ommen B, Blakemore AI, Daniel H. Determinants of postprandial plasma bile acid kinetics in human volunteers. Am J Physiol Gastrointest Liver Physiol 2017;313:G300-12. [PMID: 28663304 DOI: 10.1152/ajpgi.00157.2017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
269 Dollé L, de La Serre CB, van Grunsven LA. Are dietary emulsifiers making us fat? Journal of Hepatology 2015;63:1045-8. [DOI: 10.1016/j.jhep.2015.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
270 Hameed B, Terrault N. Emerging Therapies for Nonalcoholic Fatty Liver Disease. Clin Liver Dis 2016;20:365-85. [PMID: 27063275 DOI: 10.1016/j.cld.2015.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
271 Du Q, Zhou L, Hao K, Pan Y, Duan T. Study on the regulation of cell adhesion molecule expression and function in placenta from women with intrahepatic cholestasis of pregnancy. Med Hypotheses. 2013;81:374-375. [PMID: 23810461 DOI: 10.1016/j.mehy.2013.05.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
272 Bijsmans IT, Guercini C, Ramos Pittol JM, Omta W, Milona A, Lelieveld D, Egan DA, Pellicciari R, Gioiello A, van Mil SW. The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression. Sci Rep 2015;5:14086. [PMID: 26369990 DOI: 10.1038/srep14086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
273 Weng SG, Zhang B, Wang X, Chen H. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus. Obes Surg 2017;27:2067-72. [PMID: 28233263 DOI: 10.1007/s11695-017-2599-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
274 Chondronikola M, Harris LL, Klein S. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? J Intern Med 2016;280:476-86. [PMID: 27739136 DOI: 10.1111/joim.12527] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
275 Hucke S, Herold M, Liebmann M, Freise N, Lindner M, Fleck AK, Zenker S, Thiebes S, Fernandez-Orth J, Buck D, Luessi F, Meuth SG, Zipp F, Hemmer B, Engel DR, Roth J, Kuhlmann T, Wiendl H, Klotz L. The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion. Acta Neuropathol 2016;132:413-31. [PMID: 27383204 DOI: 10.1007/s00401-016-1593-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
276 Werling M, Vincent RP, Cross GF, Marschall HU, Fändriks L, Lönroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol. 2013;48:1257-1264. [PMID: 24044585 DOI: 10.3109/00365521.2013.833647] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
277 Kim YC, Fang S, Byun S, Seok S, Kemper B, Kemper JK. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity. Hepatology 2015;62:220-31. [PMID: 25545350 DOI: 10.1002/hep.27677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
278 Stenman LK, Holma R, Forsgård R, Gylling H, Korpela R. Higher fecal bile acid hydrophobicity is associated with exacerbation of dextran sodium sulfate colitis in mice. J Nutr 2013;143:1691-7. [PMID: 24047703 DOI: 10.3945/jn.113.180810] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
279 Zhang J, Li H, Zhou H, Fang L, Xu J, Yan H, Chen S, Song Q, Zhang Y, Xu A, Fang Q, Ye Y, Jia W. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose. Sci Rep 2017;7:6042. [PMID: 28729691 DOI: 10.1038/s41598-017-06252-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
280 Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5. [PMID: 25705637 DOI: 10.3978/j.issn.2305-5839] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
281 Bui TPN, de Vos WM. Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases. Best Pract Res Clin Endocrinol Metab 2021;35:101504. [PMID: 33785319 DOI: 10.1016/j.beem.2021.101504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Dudzik D, Zorawski M, Skotnicki M, Zarzycki W, Kozlowska G, Bibik-Malinowska K, Vallejo M, García A, Barbas C, Ramos MP. Metabolic fingerprint of Gestational Diabetes Mellitus. J Proteomics 2014;103:57-71. [PMID: 24698665 DOI: 10.1016/j.jprot.2014.03.025] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 9.4] [Reference Citation Analysis]
283 Massafra V, Milona A, Vos HR, Ramos RJJ, Gerrits J, Willemsen ECL, Ramos Pittol JM, Ijssennagger N, Houweling M, Prinsen HCMT, Verhoeven-Duif NM, Burgering BMT, van Mil SWC. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice. Gastroenterology 2017;152:1462-1476.e10. [PMID: 28130067 DOI: 10.1053/j.gastro.2017.01.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
284 Gabbia D, Pozzo L, Zigiotto G, Roverso M, Sacchi D, Dalla Pozza A, Carrara M, Bogialli S, Floreani A, Guido M, De Martin S. Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation. PLoS One 2018;13:e0204336. [PMID: 30252871 DOI: 10.1371/journal.pone.0204336] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
285 Zhu Y, Shui X, Liang Z, Huang Z, Qi Y, He Y, Chen C, Luo H, Lei W. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review). Int J Mol Med 2020;46:936-48. [PMID: 32705240 DOI: 10.3892/ijmm.2020.4674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
286 Wang XX, Jiang T, Levi M. Nuclear hormone receptors in diabetic nephropathy. Nat Rev Nephrol 2010;6:342-51. [PMID: 20421884 DOI: 10.1038/nrneph.2010.56] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
287 Ridlon JM. Conceptualizing the Vertebrate Sterolbiome. Appl Environ Microbiol 2020;86:e00641-20. [PMID: 32503912 DOI: 10.1128/AEM.00641-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
288 Dikkers A, Tietge UJ. Biliary cholesterol secretion: More than a simple ABC. World J Gastroenterol 2010; 16(47): 5936-5945 [PMID: 21157969 DOI: 10.3748/wjg.v16.i47.5936] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
289 Gelaye B, Clish CB, Denis M, Larrabure G, Tadesse MG, Deik A, Pierce K, Bullock K, Dennis C, Enquobahrie DA, Williams MA. Metabolomics signatures associated with an oral glucose challenge in pregnant women. Diabetes Metab. 2019;45:39-46. [PMID: 29395809 DOI: 10.1016/j.diabet.2018.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
290 Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017;5:11-19. [PMID: 28110300 DOI: 10.1093/gastro/gow047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
291 Fiorucci S, Biagioli M, Baldoni M, Ricci P, Sepe V, Zampella A, Distrutti E. The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease. Expert Opin Drug Discov 2021;:1-16. [PMID: 33849361 DOI: 10.1080/17460441.2021.1916465] [Reference Citation Analysis]
292 Hadi A, Arab A, Khalesi S, Rafie N, Kafeshani M, Kazemi M. Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials. Clin Nutr 2021;40:4662-73. [PMID: 34237694 DOI: 10.1016/j.clnu.2021.05.027] [Reference Citation Analysis]
293 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
294 Song W, Yang HB, Chen P, Wang SM, Zhao LP, Xu WH, Fan HF, Gu X, Chen LY. Apoptosis of human gastric carcinoma SGC-7901 induced by deoxycholic acid via the mitochondrial-dependent pathway. Appl Biochem Biotechnol 2013;171:1061-71. [PMID: 23943012 DOI: 10.1007/s12010-013-0417-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
295 Mistry RH, Borewicz K, Gu F, Verkade HJ, Schols HA, Smidt H, Tietge UJF. Dietary Isomalto/Malto‐Polysaccharides Increase Fecal Bulk and Microbial Fermentation in Mice. Mol Nutr Food Res 2020;64:2000251. [DOI: 10.1002/mnfr.202000251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
296 Erken R, Andre P, Roy E, Kootstra N, Barzic N, Girma H, Laveille C, Radreau-Pierini P, Darteil R, Vonderscher J, Scalfaro P, Tangkijvanich P, Flisiak R, Reesink H. Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study. J Viral Hepat 2021;28:1690-8. [PMID: 34467593 DOI: 10.1111/jvh.13608] [Reference Citation Analysis]
297 Sansbury BE, Bhatnagar A, Hill BG. Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice. Front Physiol 2014;5:453. [PMID: 25505420 DOI: 10.3389/fphys.2014.00453] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
298 Rodríguez-Antonio I, López-Sánchez GN, Garrido-Camacho VY, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. HPB (Oxford) 2020;22:1513-20. [PMID: 32773176 DOI: 10.1016/j.hpb.2020.07.011] [Reference Citation Analysis]
299 Luo Z, Lei H, Sun Y, Liu X, Su D. Orosomucoid, an acute response protein with multiple modulating activities. J Physiol Biochem 2015;71:329-40. [DOI: 10.1007/s13105-015-0389-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 10.1] [Reference Citation Analysis]
300 Rosales R, Romero MR, Vaquero J, Monte MJ, Requena P, Martinez-Augustin O, Sanchez de Medina F, Marin JJ. FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver. Biochem Pharmacol 2013;85:829-38. [PMID: 23313557 DOI: 10.1016/j.bcp.2013.01.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
301 Rich MK, Nouri E, Courty PE, Reinhardt D. Diet of Arbuscular Mycorrhizal Fungi: Bread and Butter? Trends Plant Sci 2017;22:652-60. [PMID: 28622919 DOI: 10.1016/j.tplants.2017.05.008] [Cited by in Crossref: 73] [Cited by in F6Publishing: 52] [Article Influence: 14.6] [Reference Citation Analysis]
302 Duez H, Staels B. Rev-erb-alpha: an integrator of circadian rhythms and metabolism. J Appl Physiol (1985) 2009;107:1972-80. [PMID: 19696364 DOI: 10.1152/japplphysiol.00570.2009] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 6.7] [Reference Citation Analysis]
303 Johansson A, Curran JE, Johnson MP, Freed KA, Fenstad MH, Bjørge L, Eide IP, Carless MA, Rainwater DL, Goring HH, Austgulen R, Moses EK, Blangero J. Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. Eur J Hum Genet 2011;19:796-800. [PMID: 21343950 DOI: 10.1038/ejhg.2011.19] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
304 Goncalves D, Barataud A, De Vadder F, Vinera J, Zitoun C, Duchampt A, Mithieux G. Bile Routing Modification Reproduces Key Features of Gastric Bypass in Rat. Ann Surg 2015;262:1006-15. [PMID: 25575265 DOI: 10.1097/SLA.0000000000001121] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
305 Trzeciak P, Herbet M. Role of the Intestinal Microbiome, Intestinal Barrier and Psychobiotics in Depression. Nutrients 2021;13:927. [PMID: 33809367 DOI: 10.3390/nu13030927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
306 Eggink HM, Oosterman JE, de Goede P, de Vries EM, Foppen E, Koehorst M, Groen AK, Boelen A, Romijn JA, la Fleur SE, Soeters MR, Kalsbeek A. Complex interaction between circadian rhythm and diet on bile acid homeostasis in male rats. Chronobiol Int 2017;34:1339-53. [PMID: 29028359 DOI: 10.1080/07420528.2017.1363226] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
307 Vlaardingerbroek H, Ng K, Stoll B, Benight N, Chacko S, Kluijtmans LA, Kulik W, Squires EJ, Olutoye O, Schady D, Finegold ML, van Goudoever JB, Burrin DG. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. J Lipid Res 2014;55:466-77. [PMID: 24478031 DOI: 10.1194/jlr.M044545] [Cited by in Crossref: 59] [Cited by in F6Publishing: 22] [Article Influence: 7.4] [Reference Citation Analysis]
308 Baes M, Van Veldhoven PP. Hepatic dysfunction in peroxisomal disorders. Biochim Biophys Acta. 2016;1863:956-970. [PMID: 26453805 DOI: 10.1016/j.bbamcr.2015.09.035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
309 Studer E, Zhou X, Zhao R, Wang Y, Takabe K, Nagahashi M, Pandak WM, Dent P, Spiegel S, Shi R, Xu W, Liu X, Bohdan P, Zhang L, Zhou H, Hylemon PB. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 2012;55:267-76. [PMID: 21932398 DOI: 10.1002/hep.24681] [Cited by in Crossref: 156] [Cited by in F6Publishing: 149] [Article Influence: 14.2] [Reference Citation Analysis]
310 Guan L, Miao P. Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer. European Journal of Pharmacology 2020;889:173616. [DOI: 10.1016/j.ejphar.2020.173616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Kowdley KV, Luketic V, Chapman R, Hirschfield GM, Poupon R, Schramm C, Vincent C, Rust C, Parés A, Mason A, Marschall HU, Shapiro D, Adorini L, Sciacca C, Beecher-Jones T, Böhm O, Pencek R, Jones D; Obeticholic Acid PBC Monotherapy Study Group. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis. Hepatology 2018;67:1890-902. [PMID: 29023915 DOI: 10.1002/hep.29569] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 27.5] [Reference Citation Analysis]
312 Reich M, Deutschmann K, Sommerfeld A, Klindt C, Kluge S, Kubitz R, Ullmer C, Knoefel WT, Herebian D, Mayatepek E, Häussinger D, Keitel V. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro. Gut 2016;65:487-501. [PMID: 26420419 DOI: 10.1136/gutjnl-2015-309458] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 12.7] [Reference Citation Analysis]
313 Fan Y, Ding W, Zhang C, Fu L, Xu D, Chen X. Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3. International Immunopharmacology 2019;77:105911. [DOI: 10.1016/j.intimp.2019.105911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
314 Sheng L, Jena PK, Hu Y, Liu HX, Nagar N, Kalanetra KM, French SW, Mills DA, Wan YY. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.J Pathol. 2017;243:431-441. [PMID: 28892150 DOI: 10.1002/path.4983] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 11.2] [Reference Citation Analysis]
315 Huang H, Si P, Wang L, Xu Y, Xu X, Zhu J, Jiang H, Li W, Chen L, Li J. Design, Synthesis, and Biological Evaluation of Novel Nonsteroidal Farnesoid X Receptor (FXR) Antagonists: Molecular Basis of FXR Antagonism. ChemMedChem 2015;10:1184-99. [DOI: 10.1002/cmdc.201500136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
316 Marschall HU, Katsika D, Rudling M, Einarsson C. The genetic background of gallstone formation: an update. Biochem Biophys Res Commun. 2010;396:58-62. [PMID: 20494111 DOI: 10.1016/j.bbrc.2010.02.143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
317 Zhao K, He J, Zhang Y, Xu Z, Xiong H, Gong R, Li S, Chen S, He F. Activation of FXR protects against renal fibrosis via suppressing Smad3 expression. Sci Rep 2016;6:37234. [PMID: 27853248 DOI: 10.1038/srep37234] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
318 Hansen M, Sonne DP, Mikkelsen KH, Gluud LL, Vilsbøll T, Knop FK. Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials. BMJ Open 2012;2:e001803. [PMID: 23148345 DOI: 10.1136/bmjopen-2012-001803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
319 Fraile JM, Palliyil S, Barelle C, Porter AJ, Kovaleva M. Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease. Drug Des Devel Ther 2021;15:3997-4009. [PMID: 34588764 DOI: 10.2147/DDDT.S315724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
320 Gadaleta RM, Garcia-Irigoyen O, Cariello M, Scialpi N, Peres C, Vetrano S, Fiorino G, Danese S, Ko B, Luo J, Porru E, Roda A, Sabbà C, Moschetta A. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor. EBioMedicine 2020;54:102719. [PMID: 32259714 DOI: 10.1016/j.ebiom.2020.102719] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
321 Chen W, Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites 2021;11:869. [PMID: 34940628 DOI: 10.3390/metabo11120869] [Reference Citation Analysis]
322 Miyata M, Hata T, Yamakawa H, Kagawa T, Yoshinari K, Yamazoe Y. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19. J Steroid Biochem Mol Biol 2012;132:41-7. [PMID: 22561792 DOI: 10.1016/j.jsbmb.2012.04.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
323 Zhang L, Wang YD, Chen WD, Wang X, Lou G, Liu N, Lin M, Forman BM, Huang W. Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice. Hepatology. 2012;56:2336-2343. [PMID: 22711662 DOI: 10.1002/hep.25905] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
324 Weickert MO, Hattersley JG, Kyrou I, Arafat AM, Rudovich N, Roden M, Nowotny P, von Loeffelholz C, Matysik S, Schmitz G, Pfeiffer AFH. Effects of supplemented isoenergetic diets varying in cereal fiber and protein content on the bile acid metabolic signature and relation to insulin resistance. Nutr Diabetes 2018;8:11. [PMID: 29549243 DOI: 10.1038/s41387-018-0020-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
325 Yin P, Xie S, Zhuang Z, He X, Tang X, Tian L, Liu Y, Niu J. Dietary supplementation of bile acid attenuate adverse effects of high-fat diet on growth performance, antioxidant ability, lipid accumulation and intestinal health in juvenile largemouth bass (Micropterus salmoides). Aquaculture 2021;531:735864. [DOI: 10.1016/j.aquaculture.2020.735864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
326 Zhan K, Zheng H, Li J, Wu H, Qin S, Luo L, Huang S. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. Biomed Res Int 2020;2020:3828249. [PMID: 33274207 DOI: 10.1155/2020/3828249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Zhang L, Xie C, Nichols RG, Chan SH, Jiang C, Hao R, Smith PB, Cai J, Simons MN, Hatzakis E, Maranas CD, Gonzalez FJ, Patterson AD. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism. mSystems. 2016;1. [PMID: 27822554 DOI: 10.1128/msystems.00070-16] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 9.2] [Reference Citation Analysis]
328 Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corcetto F, Corno C, Maneschi E, Pini A, Adorini L, Vannelli GB, Maggi M, Vignozzi L. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. J Steroid Biochem Mol Biol 2017;168:26-37. [PMID: 28115235 DOI: 10.1016/j.jsbmb.2017.01.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
329 Shibue K, Yamane S, Harada N, Hamasaki A, Suzuki K, Joo E, Iwasaki K, Nasteska D, Harada T, Hayashi Y, Adachi Y, Owada Y, Takayanagi R, Inagaki N. Fatty acid-binding protein 5 regulates diet-induced obesity via GIP secretion from enteroendocrine K cells in response to fat ingestion. Am J Physiol Endocrinol Metab 2015;308:E583-91. [PMID: 25628425 DOI: 10.1152/ajpendo.00543.2014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
330 Ding L, Xu ZJ, Shi HH, Xue CH, Huang QR, Yanagita T, Wang YM, Zhang TT. Sterol sulfate alleviates atherosclerosis via mediating hepatic cholesterol metabolism in ApoE-/- mice. Food Funct 2021;12:4887-96. [PMID: 33977967 DOI: 10.1039/d0fo03266b] [Reference Citation Analysis]
331 Lefebvre P, Staels B. DCo(H2)ding the metabolic functions of SIRT1 in the intestine. Gastroenterology 2014;146:893-6. [PMID: 24566103 DOI: 10.1053/j.gastro.2014.02.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
332 Zhao Y, Zhang Y, Wang G, Han R, Xie X. Effects of chlorpyrifos on the gut microbiome and urine metabolome in mouse (Mus musculus). Chemosphere 2016;153:287-93. [DOI: 10.1016/j.chemosphere.2016.03.055] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 9.3] [Reference Citation Analysis]
333 Duboc H, Taché Y, Hofmann AF. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis 2014;46:302-12. [PMID: 24411485 DOI: 10.1016/j.dld.2013.10.021] [Cited by in Crossref: 229] [Cited by in F6Publishing: 216] [Article Influence: 28.6] [Reference Citation Analysis]
334 Zhu J, Ye Y, Ning M, Mándi A, Feng Y, Zou Q, Kurtán T, Leng Y, Shen J. Design, Synthesis, and Structure-Activity Relationships of 3,4,5-Trisubstituted 4,5-Dihydro-1,2,4-oxadiazoles as TGR5 Agonists. ChemMedChem 2013;8:1210-23. [DOI: 10.1002/cmdc.201300144] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
335 Xie C, Huang W, Young RL, Jones KL, Horowitz M, Rayner CK, Wu T. Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease. Nutrients 2021;13:1104. [PMID: 33800566 DOI: 10.3390/nu13041104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
336 Suzuki T, Aoyama J, Hashimoto M, Ohara M, Futami-Suda S, Suzuki K, Ouchi M, Igari Y, Watanabe K, Nakano H. Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects. Clin Biochem 2014;47:1128-31. [PMID: 24794786 DOI: 10.1016/j.clinbiochem.2014.04.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
337 Giummarra L, Crewther SG, Riddell N, Murphy MJ, Crewther DP. Pathway analysis identifies altered mitochondrial metabolism, neurotransmission, structural pathways and complement cascade in retina/RPE/ choroid in chick model of form-deprivation myopia. PeerJ 2018;6:e5048. [PMID: 29967729 DOI: 10.7717/peerj.5048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
338 Kim H, Bartley GE, Rimando AM, Yokoyama W. Hepatic Gene Expression Related to Lower Plasma Cholesterol in Hamsters Fed High-Fat Diets Supplemented with Blueberry Peels and Peel Extract. J Agric Food Chem 2010;58:3984-91. [DOI: 10.1021/jf903230s] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
339 Valentini L, Gläser S, Schuetz T, Omar A, Kasim E, Kroencke T, Tietge UJ, Lochs H, Schulzke J, Brabant G, Ockenga J. Serum bile acids and leptin interact with glucose metabolism in patients with liver cirrhosis. Clinical Nutrition 2013;32:122-9. [DOI: 10.1016/j.clnu.2012.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
340 Xu JY, Li ZP, Zhang L, Ji G. Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(37): 13493-13500 [PMID: 25309079 DOI: 10.3748/wjg.v20.i37.13493] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
341 Dopico AM, Bukiya AN. Regulation of Ca2+-Sensitive K+ Channels by Cholesterol and Bile Acids via Distinct Channel Subunits and Sites. Curr Top Membr 2017;80:53-93. [PMID: 28863822 DOI: 10.1016/bs.ctm.2017.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
342 Jin ZL, Liu W. Progress in treatment of type 2 diabetes by bariatric surgery. World J Diabetes 2021; 12(8): 1187-1199 [PMID: 34512886 DOI: 10.4239/wjd.v12.i8.1187] [Reference Citation Analysis]
343 Braun K, Oeckl J, Westermeier J, Li Y, Klingenspor M. Non-adrenergic control of lipolysis and thermogenesis in adipose tissues. J Exp Biol 2018;221:jeb165381. [PMID: 29514884 DOI: 10.1242/jeb.165381] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
344 Busnelli M, Manzini S, Chiesa G. The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease. Nutrients 2019;12:E79. [PMID: 31892152 DOI: 10.3390/nu12010079] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
345 Iracheta-Vellve A, Calenda CD, Petrasek J, Ambade A, Kodys K, Adorini L, Szabo G. FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice. Hepatol Commun. 2018;2:1379-1391. [PMID: 30411084 DOI: 10.1002/hep4.1256] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
346 Voloshyna I, Reiss AB. The ABC transporters in lipid flux and atherosclerosis. Progress in Lipid Research 2011;50:213-24. [DOI: 10.1016/j.plipres.2011.02.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
347 Rössger K, Charpin-El-Hamri G, Fussenegger M. Bile acid-controlled transgene expression in mammalian cells and mice. Metab Eng 2014;21:81-90. [PMID: 24280297 DOI: 10.1016/j.ymben.2013.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
348 Bilodeau S, Caron V, Gagnon J, Kuftedjian A, Tremblay A. A CK2-RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR. J Mol Cell Biol 2017;9:195-208. [PMID: 28201649 DOI: 10.1093/jmcb/mjx009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
349 Stanimirov B, Stankov K, Mikov M. Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases. Hepatobiliary Pancreat Dis Int 2015;14:18-33. [PMID: 25655287 DOI: 10.1016/s1499-3872(14)60307-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
350 Nervi F, Arrese M. Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? Am J Gastroenterol. 2013;108:959-961. [PMID: 23735917 DOI: 10.1038/ajg.2013.84] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
351 Schippa S, Conte MP. Dysbiotic events in gut microbiota: impact on human health. Nutrients 2014;6:5786-805. [PMID: 25514560 DOI: 10.3390/nu6125786] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 12.0] [Reference Citation Analysis]
352 Le N, Cregger M, Brown V, Loret de Mola J, Bremer P, Nguyen L, Groesch K, Wilson T, Diaz-Sylvester P, Braundmeier-Fleming A. Association of microbial dynamics with urinary estrogens and estrogen metabolites in patients with endometriosis. PLoS One 2021;16:e0261362. [PMID: 34914785 DOI: 10.1371/journal.pone.0261362] [Reference Citation Analysis]
353 Mikó E, Kovács T, Sebő É, Tóth J, Csonka T, Ujlaki G, Sipos A, Szabó J, Méhes G, Bai P. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells 2019;8:E293. [PMID: 30934972 DOI: 10.3390/cells8040293] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
354 Miyata M, Yamakawa H, Hamatsu M, Kuribayashi H, Takamatsu Y, Yamazoe Y. Enterobacteria modulate intestinal bile acid transport and homeostasis through apical sodium-dependent bile acid transporter (SLC10A2) expression. J Pharmacol Exp Ther. 2011;336:188-196. [PMID: 20884752 DOI: 10.1124/jpet.110.171736] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
355 Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome 2020;8:36. [PMID: 32169105 DOI: 10.1186/s40168-020-00821-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 26.0] [Reference Citation Analysis]
356 Groen AK, Bloks VW, Verkade H, Kuipers F. Cross-talk between liver and intestine in control of cholesterol and energy homeostasis. Mol Aspects Med. 2014;37:77-88. [PMID: 24560594 DOI: 10.1016/j.mam.2014.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
357 Choudhury D, Tuncel M, Levi M. Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol 2009;29:610-20. [PMID: 20006793 DOI: 10.1016/j.semnephrol.2009.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
358 Szalowska E, Stoopen G, Groot MJ, Hendriksen PJ, Peijnenburg AA. Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes. BMC Med Genomics 2013;6:39. [PMID: 24112857 DOI: 10.1186/1755-8794-6-39] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
359 Wahlström A, Al-Dury S, Ståhlman M, Bäckhed F, Marschall HU. Cyp3a11 is not essential for the formation of murine bile acids. Biochem Biophys Rep 2017;10:70-5. [PMID: 28955737 DOI: 10.1016/j.bbrep.2017.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
360 Feriod CN, Nguyen L, Jurczak MJ, Kruglov EA, Nathanson MH, Shulman GI, Bennett AM, Ehrlich BE. Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II. Am J Physiol Endocrinol Metab. 2014;307:E1057-E1064. [PMID: 25315698 DOI: 10.1152/ajpendo.00236.2014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
361 Shin DJ, Wang L. Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors. Handb Exp Pharmacol 2019;256:51-72. [PMID: 31230143 DOI: 10.1007/164_2019_236] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
362 Kong M, Zhu L, Bai L, Zhang X, Chen Y, Liu S, Zheng S, Pandol SJ, Han YP, Duan Z. Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol. 2014;307:G883-G893. [PMID: 25214402 DOI: 10.1152/ajpgi.00427.2013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
363 Davison KM, Lung Y, Lin SL, Tong H, Kobayashi KM, Fuller-Thomson E. Depression in middle and older adulthood: the role of immigration, nutrition, and other determinants of health in the Canadian longitudinal study on aging. BMC Psychiatry 2019;19:329. [PMID: 31690283 DOI: 10.1186/s12888-019-2309-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
364 Balderas C, Rupérez FJ, Ibañez E, Señorans J, Guerrero-Fernández J, Casado IG, Gracia-Bouthelier R, García A, Barbas C. Plasma and urine metabolic fingerprinting of type 1 diabetic children. Electrophoresis 2013;34:2882-90. [PMID: 23857511 DOI: 10.1002/elps.201300062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
365 Morelli A, Vignozzi L, Maggi M, Adorini L. Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes. Biochim Biophys Acta. 2011;1812:859-866. [PMID: 21056655 DOI: 10.1016/j.bbadis.2010.10.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
366 Ichikawa R, Takayama T, Yoneno K, Kamada N, Kitazume MT, Higuchi H, Matsuoka K, Watanabe M, Itoh H, Kanai T. Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway. Immunology. 2012;136:153-162. [PMID: 22236403 DOI: 10.1111/j.1365-2567.2012.03554.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
367 Sun L, Pang Y, Wang X, Wu Q, Liu H, Liu B, Liu G, Ye M, Kong W, Jiang C. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B 2019;9:702-10. [PMID: 31384531 DOI: 10.1016/j.apsb.2019.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
368 Lucchinetti E, Lou PH, Wawrzyniak P, Wawrzyniak M, Scharl M, Holtzhauer GA, Krämer SD, Hersberger M, Rogler G, Zaugg M. Novel Strategies to Prevent Total Parenteral Nutrition-Induced Gut and Liver Inflammation, and Adverse Metabolic Outcomes. Mol Nutr Food Res 2021;65:e1901270. [PMID: 32359213 DOI: 10.1002/mnfr.201901270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
369 Düfer M, Hörth K, Krippeit-Drews P, Drews G. The significance of the nuclear farnesoid X receptor (FXR) in β cell function. Islets 2012;4:333-8. [PMID: 23073079 DOI: 10.4161/isl.22383] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
370 Perazzo H, Dufour JF. The therapeutic landscape of non-alcoholic steatohepatitis. Liver Int. 2017;37:634-647. [PMID: 27727520 DOI: 10.1111/liv.13270] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
371 Sheng L, Jena PK, Liu HX, Hu Y, Nagar N, Bronner DN, Settles ML, Bäumler AJ, Wan YY. Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila. FASEB J 2018;:fj201800370R. [PMID: 29882708 DOI: 10.1096/fj.201800370R] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
372 Zaborska KE, Cummings BP. Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment. Curr Diab Rep 2018;18:109. [PMID: 30232649 DOI: 10.1007/s11892-018-1092-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
373 Miyazaki-Anzai S, Levi M, Kratzer A, Ting TC, Lewis LB, Miyazaki M. Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease. Circ Res 2010;106:1807-17. [PMID: 20431060 DOI: 10.1161/CIRCRESAHA.109.212969] [Cited by in Crossref: 63] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
374 Kemper JK, Choi SE, Kim DH. Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism. Vitam Horm 2013;91:385-404. [PMID: 23374725 DOI: 10.1016/B978-0-12-407766-9.00016-X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
375 Saito R, Tahara H, Shimizu S, Ohira M, Ide K, Ishiyama K, Kobayashi T, Ohdan H. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report. Surg Case Rep. 2017;3:73. [PMID: 28547740 DOI: 10.1186/s40792-017-0349-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
376 Wang DQH, Carey MC. Therapeutic uses of animal biles in traditional Chinese medicine: An ethnopharmacological, biophysical chemical and medicinal review. World J Gastroenterol 2014; 20(29): 9952-9975 [PMID: 25110425 DOI: 10.3748/wjg.v20.i29.9952] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
377 Shao S, Yang Y, Yuan G, Zhang M, Yu X. Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction. DNA Cell Biol. 2013;32:41-49. [PMID: 23347443 DOI: 10.1089/dna.2012.1874] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
378 Out C, Hageman J, Bloks VW, Gerrits H, Sollewijn Gelpke MD, Bos T, Havinga R, Smit MJ, Kuipers F, Groen AK. Liver receptor homolog-1 is critical for adequate up-regulation of Cyp7a1 gene transcription and bile salt synthesis during bile salt sequestration. Hepatology 2011;53:2075-85. [DOI: 10.1002/hep.24286] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
379 Bass JY, Caravella JA, Chen L, Creech KL, Deaton DN, Madauss KP, Marr HB, Mcfadyen RB, Miller AB, Mills WY, Navas F, Parks DJ, Smalley TL, Spearing PK, Todd D, Williams SP, Wisely GB. Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene. Bioorganic & Medicinal Chemistry Letters 2011;21:1206-13. [DOI: 10.1016/j.bmcl.2010.12.089] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
380 Han J, Liu Y, Wang R, Yang J, Ling V, Borchers CH. Metabolic profiling of bile acids in human and mouse blood by LC-MS/MS in combination with phospholipid-depletion solid-phase extraction. Anal Chem 2015;87:1127-36. [PMID: 25496250 DOI: 10.1021/ac503816u] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 11.6] [Reference Citation Analysis]
381 Silvennoinen R, Quesada H, Kareinen I, Julve J, Kaipiainen L, Gylling H, Blanco-Vaca F, Escola-Gil JC, Kovanen PT, Lee-Rueckert M. Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice. Physiol Rep 2015;3:e12402. [PMID: 25969465 DOI: 10.14814/phy2.12402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
382 Anderson AP, Rose E, Flanagan SP, Jones AG. The Estrogen-Responsive Transcriptome of Female Secondary Sexual Traits in the Gulf Pipefish. J Hered 2020;111:294-306. [PMID: 32124926 DOI: 10.1093/jhered/esaa008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
383 Yao J, Zhou CS, Ma X, Fu BQ, Tao LS, Chen M, Xu YP. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. World J Gastroenterol 2014; 20(39): 14430-14441 [PMID: 25339829 DOI: 10.3748/wjg.v20.i39.14430] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
384 Huang S, Wu Q, Liu H, Ling H, He Y, Wang C, Wang Z, Lu Y, Lu Y. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids. Journal of Ethnopharmacology 2019;241:111976. [DOI: 10.1016/j.jep.2019.111976] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
385 Dong B, Singh AB, Guo GL, Young M, Liu J. Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR. Int J Mol Med 2019;43:1927-38. [PMID: 30896855 DOI: 10.3892/ijmm.2019.4136] [Reference Citation Analysis]
386 Keitel V, Häussinger D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol 2012;36:412-9. [PMID: 22521118 DOI: 10.1016/j.clinre.2012.03.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 7.6] [Reference Citation Analysis]
387 Zhang Y, Ning G, Handelsman Y, Bloomgarden ZT. Gut hormones and the brain*: Gut hormones and the brain. Journal of Diabetes 2010;2:138-45. [DOI: 10.1111/j.1753-0407.2009.00056.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
388 Tan Y, Bi W, Zhang GX. Role and molecular mechanism of farnesoid X receptor in obstructive jaundice. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2574-2581 [DOI: 10.11569/wcjd.v23.i16.2574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
389 Ulker İ, Yildiran H. The effects of bariatric surgery on gut microbiota in patients with obesity: a review of the literature. Biosci Microbiota Food Health 2019;38:3-9. [PMID: 30705797 DOI: 10.12938/bmfh.18-018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
390 Gao F, Zhang X, Zhou L, Zhou S, Zheng Y, Yu J, Fan W, Zhu Y, Han X. Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgery. Metabolism 2016;65:78-88. [PMID: 26773931 DOI: 10.1016/j.metabol.2015.09.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
391 Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res. 2012;53:1723-1737. [PMID: 22550135 DOI: 10.1194/jlr.r024794] [Cited by in Crossref: 188] [Cited by in F6Publishing: 91] [Article Influence: 18.8] [Reference Citation Analysis]
392 Abu Bakar MH, Sarmidi MR, Cheng K, Ali Khan A, Suan CL, Zaman Huri H, Yaakob H. Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes. Mol BioSyst 2015;11:1742-74. [DOI: 10.1039/c5mb00158g] [Cited by in Crossref: 65] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
393 de Hoyos-Vega JM, Hong HJ, Stybayeva G, Revzin A. Hepatocyte cultures: From collagen gel sandwiches to microfluidic devices with integrated biosensors. APL Bioeng 2021;5:041504. [PMID: 34703968 DOI: 10.1063/5.0058798] [Reference Citation Analysis]
394 Zhu J, Ning M, Guo C, Zhang L, Pan G, Leng Y, Shen J. Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold. European Journal of Medicinal Chemistry 2013;69:55-68. [DOI: 10.1016/j.ejmech.2013.07.050] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
395 Claudel T, Zollner G, Wagner M, Trauner M. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011;1812:867-78. [DOI: 10.1016/j.bbadis.2010.12.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
396 Pols TW. TGR5 in inflammation and cardiovascular disease. Biochem Soc Trans. 2014;42:244-249. [PMID: 24646225 DOI: 10.1042/bst20130279] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
397 Tomeno W, Yoneda M, Imajo K, Ogawa Y, Kessoku T, Saito S, Eguchi Y, Nakajima A. Emerging drugs for non-alcoholic steatohepatitis. Expert Opin Emerg Drugs. 2013;18:279-290. [PMID: 23848366 DOI: 10.1517/14728214.2013.811232] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
398 van Nierop FS, Scheltema MJ, Eggink HM, Pols TW, Sonne DP, Knop FK, Soeters MR. Clinical relevance of the bile acid receptor TGR5 in metabolism. The Lancet Diabetes & Endocrinology 2017;5:224-33. [DOI: 10.1016/s2213-8587(16)30155-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 31] [Article Influence: 12.6] [Reference Citation Analysis]
399 Chen H, Li J, Zhang D, Zhou X, Xie J. Role of the fibroblast growth factor 19 in the skeletal system. Life Sci 2021;265:118804. [PMID: 33245964 DOI: 10.1016/j.lfs.2020.118804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Liu Y, Dai M. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis. Mediators Inflamm 2020;2020:4634172. [PMID: 32148438 DOI: 10.1155/2020/4634172] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
401 Csanaky IL, Aleksunes LM, Tanaka Y, Klaassen CD. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol. 2009;297:G419-G433. [PMID: 19497955 DOI: 10.1152/ajpgi.90728.2008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
402 Ma H, Patti ME. Bile acids, obesity, and the metabolic syndrome. Best Pract Res Clin Gastroenterol 2014;28:573-83. [PMID: 25194176 DOI: 10.1016/j.bpg.2014.07.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 11.0] [Reference Citation Analysis]
403 Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5. [PMID: 25705637 DOI: 10.3978/j.issn.2305-5839.2014.12.06] [Cited by in F6Publishing: 76] [Reference Citation Analysis]
404 Amai K, Fukami T, Ichida H, Watanabe A, Nakano M, Watanabe K, Nakajima M. Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers. Drug Metab Pharmacokinet 2020;35:539-47. [PMID: 33036882 DOI: 10.1016/j.dmpk.2020.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
405 Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411-428. [PMID: 31028350 DOI: 10.1038/s41575-019-0145-7] [Cited by in Crossref: 268] [Cited by in F6Publishing: 286] [Article Influence: 89.3] [Reference Citation Analysis]
406 Taylor DR, Alaghband-Zadeh J, Cross GF, Omar S, le Roux CW, Vincent RP. Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. PLoS One 2014;9:e93540. [PMID: 24736330 DOI: 10.1371/journal.pone.0093540] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
407 Govindarajan K, MacSharry J, Casey PG, Shanahan F, Joyce SA, Gahan CG. Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk. PLoS One 2016;11:e0167319. [PMID: 27907092 DOI: 10.1371/journal.pone.0167319] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
408 An P, Wei G, Huang P, Li W, Qi X, Lin Y, Vaid KA, Wang J, Zhang S, Li Y, Or YS, Jiang LJ, Popov YV. A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction. Liver Int 2020;40:1655-69. [PMID: 32329946 DOI: 10.1111/liv.14490] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
409 Urso A, D'Ovidio F, Xu D, Emala CW Sr, Bunnett NW, Perez-Zoghbi JF. Bile acids inhibit cholinergic constriction in proximal and peripheral airways from humans and rodents. Am J Physiol Lung Cell Mol Physiol 2020;318:L264-75. [PMID: 31800261 DOI: 10.1152/ajplung.00242.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
410 Andersson KE, Axling U, Xu J, Swärd K, Ahrné S, Molin G, Holm C, Hellstrand P. Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes. Eur J Nutr 2013;52:1755-69. [PMID: 23262749 DOI: 10.1007/s00394-012-0479-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
411 Puri P, Daita K, Joyce A, Mirshahi F, Santhekadur PK, Cazanave S, Luketic VA, Siddiqui MS, Boyett S, Min HK, Kumar DP, Kohli R, Zhou H, Hylemon PB, Contos MJ, Idowu M, Sanyal AJ. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology. 2018;67:534-548. [PMID: 28696585 DOI: 10.1002/hep.29359] [Cited by in Crossref: 129] [Cited by in F6Publishing: 129] [Article Influence: 25.8] [Reference Citation Analysis]
412 Greimel T, Jahnel J, Pohl S, Strini T, Tischitz M, Meier-Allard N, Holasek S, Meinel K, Aguiriano-Moser V, Zobel J, Haidl H, Gallistl S, Panzitt K, Wagner M, Schlagenhauf A. Bile acid-induced tissue factor activity in hepatocytes correlates with activation of farnesoid X receptor. Lab Invest 2021. [PMID: 34145381 DOI: 10.1038/s41374-021-00628-z] [Reference Citation Analysis]
413 Hammond CL, Wheeler SG, Ballatori N, Hinkle PM. Ostα-/- mice are not protected from western diet-induced weight gain. Physiol Rep 2015;3:e12263. [PMID: 25626867 DOI: 10.14814/phy2.12263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
414 Kuver R. The expanding universe of bile acid physiology: delving into the mysteries of dark (green) matter. J Surg Res 2013;182:207-9. [PMID: 22502870 DOI: 10.1016/j.jss.2012.03.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
415 Comeglio P, Cellai I, Mello T, Filippi S, Maneschi E, Corcetto F, Corno C, Sarchielli E, Morelli A, Rapizzi E, Bani D, Guasti D, Vannelli GB, Galli A, Adorini L, Maggi M, Vignozzi L. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. J Endocrinol 2018;238:107-27. [PMID: 29945982 DOI: 10.1530/JOE-17-0557] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
416 Zheng H, Zhang W, Zhang L, Zhang Z, Li J, Lu G, Zhu Y, Wang Y, Huang Y, Liu J, Kang H, Chen J, Wang L, Chen A, Yu S, Gao Z, Jin L, Gu W, Wang Z, Zhao L, Shi B, Wen H, Lin R, Jones MK, Brejova B, Vinar T, Zhao G, McManus DP, Chen Z, Zhou Y, Wang S. The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet 2013;45:1168-75. [PMID: 24013640 DOI: 10.1038/ng.2757] [Cited by in Crossref: 180] [Cited by in F6Publishing: 165] [Article Influence: 20.0] [Reference Citation Analysis]
417 Yang F, Takeuchi T, Tsuneyama K, Yokoi T, Oda S. Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats. Toxicol Sci 2019;170:95-108. [PMID: 30985903 DOI: 10.1093/toxsci/kfz088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
418 Wang X, Wang F, Zhang Y, Xiong H, Zhang Y, Zhuang P, Zhang Y. Diabetic cognitive dysfunction is associated with increased bile acids in liver and activation of bile acid signaling in intestine. Toxicology Letters 2018;287:10-22. [DOI: 10.1016/j.toxlet.2018.01.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
419 Burrin D, Stoll B, Moore D. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways. J Anim Sci 2013;91:1991-2000. [PMID: 23729782 DOI: 10.2527/jas.2013-6331] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
420 Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, Thadhani R, Clish CB, Greka A, Gerszten RE. Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 2010;21:1041-51. [PMID: 20378825 DOI: 10.1681/ASN.2009111132] [Cited by in Crossref: 132] [Cited by in F6Publishing: 83] [Article Influence: 11.0] [Reference Citation Analysis]
421 Wan YY, Sheng L. Regulation of bile acid receptor activity. Liver Res 2018;2:180-5. [PMID: 32280557 DOI: 10.1016/j.livres.2018.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
422 Brighton CA, Rievaj J, Kuhre RE, Glass LL, Schoonjans K, Holst JJ, Gribble FM, Reimann F. Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors. Endocrinology 2015;156:3961-70. [PMID: 26280129 DOI: 10.1210/en.2015-1321] [Cited by in Crossref: 164] [Cited by in F6Publishing: 168] [Article Influence: 23.4] [Reference Citation Analysis]
423 Annaba F, Ma K, Kumar P, Dudeja AK, Kineman RD, Shneider BL, Saksena S, Gill RK, Alrefai WA. Ileal apical Na+-dependent bile acid transporter ASBT is upregulated in rats with diabetes mellitus induced by low doses of streptozotocin. Am J Physiol Gastrointest Liver Physiol 2010;299:G898-906. [PMID: 20651004 DOI: 10.1152/ajpgi.00139.2010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
424 Li M, Wang Q, Li Y, Cao S, Zhang Y, Wang Z, Liu G, Li J, Gu B. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges. Pharmacology & Therapeutics 2020;212:107539. [DOI: 10.1016/j.pharmthera.2020.107539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
425 Naumann S, Haller D, Eisner P, Schweiggert-Weisz U. Mechanisms of Interactions between Bile Acids and Plant Compounds-A Review. Int J Mol Sci 2020;21:E6495. [PMID: 32899482 DOI: 10.3390/ijms21186495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
426 Yang X, Gonzalez FJ, Huang M, Bi H. Nuclear receptors and non-alcoholic fatty liver disease: An update. Liver Research 2020;4:88-93. [DOI: 10.1016/j.livres.2020.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
427 Noor F. A shift in paradigm towards human biology-based systems for cholestatic-liver diseases. J Physiol 2015;593:5043-55. [PMID: 26417843 DOI: 10.1113/JP271124] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
428 Smushkin G, Sathananthan M, Piccinini F, Dalla Man C, Law JH, Cobelli C, Zinsmeister AR, Rizza RA, Vella A. The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes. Diabetes 2013;62:1094-101. [PMID: 23250357 DOI: 10.2337/db12-0923] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
429 Pârvu A, Cătoi F. Is there any interplay between incretins and bile acids? What is the role of bariatric surgery? Clujul Med 2014;87:7-10. [PMID: 26527988 DOI: 10.15386/cjm.2014.8872.871.ap1fc2] [Reference Citation Analysis]
430 Panzitt K, Wagner M. FXR in liver physiology: Multiple faces to regulate liver metabolism. Biochim Biophys Acta Mol Basis Dis 2021;1867:166133. [PMID: 33771667 DOI: 10.1016/j.bbadis.2021.166133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
431 Xi Y, Li H. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease. Biomed Pharmacother 2020;121:109609. [PMID: 31731192 DOI: 10.1016/j.biopha.2019.109609] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
432 Herrema H, Meissner M, van Dijk TH, Brufau G, Boverhof R, Oosterveer MH, Reijngoud DJ, Müller M, Stellaard F, Groen AK, Kuipers F. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice. Hepatology 2010;51:806-16. [PMID: 19998408 DOI: 10.1002/hep.23408] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
433 Rezen T, Rozman D, Pascussi JM, Monostory K. Interplay between cholesterol and drug metabolism. Biochim Biophys Acta. 2011;1814:146-160. [PMID: 20570756 DOI: 10.1016/j.bbapap.2010.05.014] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
434 Akwabi-ameyaw A, Caravella JA, Chen L, Creech KL, Deaton DN, Madauss KP, Marr HB, Miller AB, Navas F, Parks DJ, Spearing PK, Todd D, Williams SP, Wisely GB. Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene. Bioorganic & Medicinal Chemistry Letters 2011;21:6154-60. [DOI: 10.1016/j.bmcl.2011.08.034] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
435 Roda A, Pellicciari R, Gioiello A, Neri F, Camborata C, Passeri D, De Franco F, Spinozzi S, Colliva C, Adorini L, Montagnani M, Aldini R. Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat. J Pharmacol Exp Ther 2014;350:56-68. [DOI: 10.1124/jpet.114.214650] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
436 Zanlungo S, Rigotti A, Miquel JF, Nervi F. Abnormalities of lipid metabolism, gallstone disease and gallbladder function. Clinical Lipidology 2011;6:315-25. [DOI: 10.2217/clp.11.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
437 Chiang J. Liver Physiology: Metabolism and Detoxification. Pathobiology of Human Disease. Elsevier; 2014. pp. 1770-82. [DOI: 10.1016/b978-0-12-386456-7.04202-7] [Cited by in Crossref: 14] [Article Influence: 1.8] [Reference Citation Analysis]
438 Li M, Vokral I, Evers B, de Graaf IAM, de Jager MH, Groothuis GMM. Human and rat precision-cut intestinal slices as ex vivo models to study bile acid uptake by the apical sodium-dependent bile acid transporter. Eur J Pharm Sci 2018;121:65-73. [PMID: 29751102 DOI: 10.1016/j.ejps.2018.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
439 Yamada S, Guo X, Wang K, Tanimoto A, Sasaguri Y. Novel function of histamine signaling via histamine receptors in cholesterol and bile acid metabolism: Histamine H2 receptor protects against nonalcoholic fatty liver disease. Pathology International 2016;66:376-85. [DOI: 10.1111/pin.12423] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
440 Stellaard F, Bloks VW, Burgerhof HG, Scheltema RA, Murphy EJ, Romijn HA, Smelt GH, Brufau G, Kuipers F. Two time-point assessment of bile acid kinetics in humans using stable isotopes. Isotopes Environ Health Stud 2010;46:325-36. [PMID: 20645205 DOI: 10.1080/10256016.2010.503894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
441 Abdelkarim M, Caron S, Duhem C, Prawitt J, Dumont J, Lucas A, Bouchaert E, Briand O, Brozek J, Kuipers F. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. J Biol Chem. 2010;285:36759-36767. [PMID: 20851881 DOI: 10.1074/jbc.m110.166231] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
442 de Boer JF, Bloks VW, Verkade E, Heiner-fokkema MR, Kuipers F. New insights in the multiple roles of bile acids and their signaling pathways in metabolic control: . Current Opinion in Lipidology 2018;29:194-202. [DOI: 10.1097/mol.0000000000000508] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 7.8] [Reference Citation Analysis]
443 Heidker RM, Caiozzi GC, Ricketts ML. Dietary procyanidins selectively modulate intestinal farnesoid X receptor-regulated gene expression to alter enterohepatic bile acid recirculation: elucidation of a novel mechanism to reduce triglyceridemia. Mol Nutr Food Res 2016;60:727-36. [PMID: 26718753 DOI: 10.1002/mnfr.201500795] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
444 Gass M, Beglinger C, Peterli R. Metabolic surgery-principles and current concepts. Langenbecks Arch Surg 2011;396:949-72. [PMID: 21870176 DOI: 10.1007/s00423-011-0834-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
445 Xue X, Hixson SM, Hori TS, Booman M, Parrish CC, Anderson DM, Rise ML. Atlantic salmon (Salmo salar) liver transcriptome response to diets containing Camelina sativa products. Comp Biochem Physiol Part D Genomics Proteomics 2015;14:1-15. [PMID: 25681993 DOI: 10.1016/j.cbd.2015.01.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
446 Alvarez-figueroa MJ, Muggli-galaz C, González PM. Effect of the aggregation state of bile salts on their transdermal absorption enhancing properties. Journal of Drug Delivery Science and Technology 2019;54:101333. [DOI: 10.1016/j.jddst.2019.101333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
447 Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics. 2011;5:71-86. [PMID: 21847343 DOI: 10.2147/btt.s19099] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
448 La Frano MR, Hernandez-Carretero A, Weber N, Borkowski K, Pedersen TL, Osborn O, Newman JW. Diet-induced obesity and weight loss alter bile acid concentrations and bile acid-sensitive gene expression in insulin target tissues of C57BL/6J mice. Nutr Res 2017;46:11-21. [PMID: 29173647 DOI: 10.1016/j.nutres.2017.07.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
449 Claro da Silva T, Polli JE, Swaan PW. The solute carrier family 10 (SLC10): beyond bile acid transport. Mol Aspects Med 2013;34:252-69. [PMID: 23506869 DOI: 10.1016/j.mam.2012.07.004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 10.0] [Reference Citation Analysis]
450 Liu Z, Law W, Wang D, Nie X, Sheng D, Song G, Guo K, Wei P, Ouyang P, Wong C, Zhou G. Synthesis and discovery of andrographolide derivatives as non-steroidal farnesoid X receptor (FXR) antagonists. RSC Adv 2014;4:13533-45. [DOI: 10.1039/c3ra46715e] [Cited by in Crossref: 18] [Article Influence: 2.3] [Reference Citation Analysis]
451 Brønden A, Knop FK. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology. J Clin Endocrinol Metab 2020;105:dgz025. [PMID: 31630179 DOI: 10.1210/clinem/dgz025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
452 Lin R, Zhan M, Yang L, Wang H, Shen H, Huang S, Huang X, Xu S, Zhang Z, Li W, Liu Q, Shi Y, Chen W, Yu J, Wang J. Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation. Oncogene 2020;39:4983-5000. [PMID: 32514152 DOI: 10.1038/s41388-020-1349-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
453 Li P, Zhu L, Yang X, Li W, Sun X, Yi B, Zhu S. Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell. J Cell Physiol 2019;234:12839-46. [PMID: 30536761 DOI: 10.1002/jcp.27940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
454 Liao BM, McManus SA, Hughes WE, Schmitz-Peiffer C. Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes. Mol Endocrinol 2016;30:417-28. [PMID: 26886171 DOI: 10.1210/me.2015-1217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
455 Walker A, Pfitzner B, Neschen S, Kahle M, Harir M, Lucio M, Moritz F, Tziotis D, Witting M, Rothballer M, Engel M, Schmid M, Endesfelder D, Klingenspor M, Rattei T, Castell WZ, de Angelis MH, Hartmann A, Schmitt-Kopplin P. Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. ISME J 2014;8:2380-96. [PMID: 24906017 DOI: 10.1038/ismej.2014.79] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
456 Olivera-Castillo L, Davalos A, Grant G, Valadez-Gonzalez N, Montero J, Barrera-Perez HA, Chim-Chi Y, Olvera-Novoa MA, Ceja-Moreno V, Acereto-Escoffie P, Rubio-Piña J, Rodriguez-Canul R. Diets containing sea cucumber (Isostichopus badionotus) meals are hypocholesterolemic in young rats. PLoS One 2013;8:e79446. [PMID: 24260223 DOI: 10.1371/journal.pone.0079446] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
457 Kim DH, Xiao Z, Kwon S, Sun X, Ryerson D, Tkac D, Ma P, Wu SY, Chiang CM, Zhou E, Xu HE, Palvimo JJ, Chen LF, Kemper B, Kemper JK. A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO J 2015;34:184-99. [PMID: 25425577 DOI: 10.15252/embj.201489527] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
458 Yuan YW, Wang L, Lu ZY, Long Y, Jiao YF, Xia Q, Wen DX, Yu WF. Overexcited MaxiK and KATP channels underlie obstructive jaundice-induced vasoconstrictor hyporeactivity of arterial smooth muscle. Sci Rep 2016;6:39246. [PMID: 28000721 DOI: 10.1038/srep39246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
459 Wang F, Lu Z, Wang X, Zhang Y. Impaired vagus function in rats suppresses bile acid synthesis in the liver by disrupting tight junctions and activating Fxr-Fgf15 signaling in the intestine. Biochemical and Biophysical Research Communications 2018;495:1490-6. [DOI: 10.1016/j.bbrc.2017.11.201] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
460 Kumagai A, Fukushima J, Takikawa H, Fukuda T, Fukusato T. Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma. Hepatol Res 2013;43:959-69. [PMID: 23369163 DOI: 10.1111/hepr.12047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
461 Hassan HM, Isovic M, Kolendowski B, Bauer-Maison N, Onabote O, Cecchini M, Haig A, Maleki Vareki S, Underhill TM, Torchia J. Loss of Thymine DNA Glycosylase Causes Dysregulation of Bile Acid Homeostasis and Hepatocellular Carcinoma. Cell Rep 2020;31:107475. [PMID: 32268085 DOI: 10.1016/j.celrep.2020.03.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
462 Chen Y, Yang H, Wu Z, Liu G, Tang Y, Li W. Prediction of Farnesoid X Receptor Disruptors with Machine Learning Methods. Chem Res Toxicol 2018;31:1128-37. [DOI: 10.1021/acs.chemrestox.8b00162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
463 Morelli A, Comeglio P, Filippi S, Sarchielli E, Cellai I, Vignozzi L, Yehiely-cohen R, Maneschi E, Gacci M, Carini M, Adorini L, Vannelli GB, Maggi M. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. The Journal of Steroid Biochemistry and Molecular Biology 2012;132:80-92. [DOI: 10.1016/j.jsbmb.2012.02.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
464 Wagner M, Trauner M. Recent advances in understanding and managing cholestasis. F1000Res 2016;5:F1000 Faculty Rev-705. [PMID: 27134744 DOI: 10.12688/f1000research.8012.1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
465 Mehlmann JF, Crawley ML, Lundquist JT, Unwalla RJ, Harnish DC, Evans MJ, Kim CY, Wrobel JE, Mahaney PE. Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR). Bioorganic & Medicinal Chemistry Letters 2009;19:5289-92. [DOI: 10.1016/j.bmcl.2009.07.148] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
466 Peng Z, Chen J, Drachenberg CB, Raufman JP, Xie G. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer. J Biol Chem 2019;294:8529-42. [PMID: 30967475 DOI: 10.1074/jbc.RA118.004361] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
467 Szalowska E, Pronk TE, Peijnenburg AA. Cyclosporin A induced toxicity in mouse liver slices is only slightly aggravated by Fxr-deficiency and co-occurs with upregulation of pro-inflammatory genes and downregulation of genes involved in mitochondrial functions. BMC Genomics 2015;16:822. [PMID: 26482353 DOI: 10.1186/s12864-015-2054-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
468 Hu C, Liu M, Wan T, Tang L, Sun B, Zhou B, Lam JCW, Lam PKS, Chen L. Disturbances in Microbial and Metabolic Communication across the Gut-Liver Axis Induced by a Dioxin-like Pollutant: An Integrated Metagenomics and Metabolomics Analysis. Environ Sci Technol 2021;55:529-37. [PMID: 33356191 DOI: 10.1021/acs.est.0c06884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
469 Hines KM, Ashfaq S, Davidson JM, Opalenik SR, Wikswo JP, McLean JA. Biomolecular signatures of diabetic wound healing by structural mass spectrometry. Anal Chem 2013;85:3651-9. [PMID: 23452326 DOI: 10.1021/ac303594m] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
470 Maqdasy S, Baptissart M, Vega A, Baron S, Lobaccaro JM, Volle DH. Cholesterol and male fertility: what about orphans and adopted? Mol Cell Endocrinol 2013;368:30-46. [PMID: 22766106 DOI: 10.1016/j.mce.2012.06.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
471 de Oliveira MC, Gilglioni EH, de Boer BA, Runge JH, de Waart DR, Salgueiro CL, Ishii-Iwamoto EL, Oude Elferink RP, Gaemers IC. Bile acid receptor agonists INT747 and INT777 decrease oestrogen deficiency-related postmenopausal obesity and hepatic steatosis in mice. Biochim Biophys Acta 2016;1862:2054-62. [PMID: 27475255 DOI: 10.1016/j.bbadis.2016.07.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
472 Lee CG, Kim YW, Kim EH, Meng Z, Huang W, Hwang SJ, Kim SG. Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology. 2012;142:1206-1217.e7. [PMID: 22265968 DOI: 10.1053/j.gastro.2012.01.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
473 Jin L, Feng X, Rong H, Pan Z, Inaba Y, Qiu L, Zheng W, Lin S, Wang R, Wang Z, Wang S, Liu H, Li S, Xie W, Li Y. The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism. Nat Commun 2013;4:1937. [PMID: 23728580 DOI: 10.1038/ncomms2924] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 8.0] [Reference Citation Analysis]
474 Velazquez-Villegas LA, Perino A, Lemos V, Zietak M, Nomura M, Pols TWH, Schoonjans K. TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue. Nat Commun 2018;9:245. [PMID: 29339725 DOI: 10.1038/s41467-017-02068-0] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 19.3] [Reference Citation Analysis]
475 Zhang ZM, Yang L, Wan Y, Liu C, Jiang S, Shang EX, Duan JA. Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1174:122728. [PMID: 33975272 DOI: 10.1016/j.jchromb.2021.122728] [Reference Citation Analysis]
476 Zhang C, Wang Z, Feng Q, Chen WD, Wang YD. Farnesoid X receptor: a potential therapeutic target in multiple organs. Histol Histopathol 2020;35:1403-14. [PMID: 33393073 DOI: 10.14670/HH-18-301] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
477 Fu S, Fan J, Blanco J, Gimenez-Cassina A, Danial NN, Watkins SM, Hotamisligil GS. Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting. PLoS Genet 2012;8:e1002902. [PMID: 22927828 DOI: 10.1371/journal.pgen.1002902] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
478 Mangalam A, Poisson L, Nemutlu E, Datta I, Denic A, Dzeja P, Rodriguez M, Rattan R, Giri S. Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics. J Clin Cell Immunol 2013;4. [PMID: 24273690 DOI: 10.4172/2155-9899.1000150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
479 Lee YY, Hong SH, Lee YJ, Chung SS, Jung HS, Park SG, Park KS. Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress. Biochem Biophys Res Commun 2010;397:735-9. [PMID: 20541525 DOI: 10.1016/j.bbrc.2010.06.022] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
480 Zhang S, Jin Y, Zeng Z, Liu Z, Fu Z. Subchronic Exposure of Mice to Cadmium Perturbs Their Hepatic Energy Metabolism and Gut Microbiome. Chem Res Toxicol 2015;28:2000-9. [DOI: 10.1021/acs.chemrestox.5b00237] [Cited by in Crossref: 111] [Cited by in F6Publishing: 103] [Article Influence: 15.9] [Reference Citation Analysis]
481 Hernández SB, Cava F, Pucciarelli MG, García-Del Portillo F, de Pedro MA, Casadesús J. Bile-induced peptidoglycan remodelling in Salmonella enterica. Environ Microbiol 2015;17:1081-9. [PMID: 24762004 DOI: 10.1111/1462-2920.12491] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
482 Marciano DP, Chang MR, Corzo CA, Goswami D, Lam VQ, Pascal BD, Griffin PR. The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and Rev-erbs. Cell Metab 2014;19:193-208. [PMID: 24440037 DOI: 10.1016/j.cmet.2013.12.009] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 9.6] [Reference Citation Analysis]
483 Meissner M, Herrema H, van Dijk TH, Gerding A, Havinga R, Boer T, Müller M, Reijngoud DJ, Groen AK, Kuipers F. Bile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance rate. PLoS One 2011;6:e24564. [PMID: 22087215 DOI: 10.1371/journal.pone.0024564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
484 Kumar DP, Asgharpour A, Mirshahi F, Park SH, Liu S, Imai Y, Nadler JL, Grider JR, Murthy KS, Sanyal AJ. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis. J Biol Chem 2016;291:6626-40. [PMID: 26757816 DOI: 10.1074/jbc.M115.699504] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
485 Chen MJ, Liu C, Wan Y, Yang L, Jiang S, Qian DW, Duan JA. Enterohepatic circulation of bile acids and their emerging roles on glucolipid metabolism. Steroids 2021;165:108757. [PMID: 33161055 DOI: 10.1016/j.steroids.2020.108757] [Reference Citation Analysis]
486 Duan J, Zhou J, Ren F, Tan C, Wang S, Yuan L. Mid to distal small bowel resection with the preservation of the terminal ileum improves glucose homeostasis in diabetic rats by activating the hindgut-dependent mechanism. J Gastrointest Surg 2014;18:1186-93. [PMID: 24687254 DOI: 10.1007/s11605-014-2507-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
487 Ploton M, Mazuy C, Gheeraert C, Dubois V, Berthier A, Dubois-Chevalier J, Maréchal X, Bantubungi K, Diemer H, Cianférani S, Strub JM, Helleboid-Chapman A, Eeckhoute J, Staels B, Lefebvre P. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis. J Hepatol 2018;69:1099-109. [PMID: 29981427 DOI: 10.1016/j.jhep.2018.06.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
488 Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res 2009;50:2340-57. [PMID: 19498215 DOI: 10.1194/jlr.R900012-JLR200] [Cited by in Crossref: 401] [Cited by in F6Publishing: 201] [Article Influence: 30.8] [Reference Citation Analysis]
489 Wang JC, Gray NE, Kuo T, Harris CA. Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci 2012;2:19. [PMID: 22640645 DOI: 10.1186/2045-3701-2-19] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
490 Cao L, Che Y, Meng T, Deng S, Zhang J, Zhao M, Xu W, Wang D, Pu Z, Wang G, Hao H. Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer. Oncotarget 2017;8:63665-79. [PMID: 28969019 DOI: 10.18632/oncotarget.18885] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
491 Lee SH, Choi JM, Jung SY, Cox AR, Hartig SM, Moore DD, Kim KH. The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation. Biochem Biophys Res Commun 2021;534:864-70. [PMID: 33168190 DOI: 10.1016/j.bbrc.2020.10.086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
492 Guo C, LaCerte C, Edwards JE, Brouwer KR, Brouwer KLR. Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms. J Pharmacol Exp Ther 2018;365:413-21. [PMID: 29487110 DOI: 10.1124/jpet.117.246033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
493 Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice. Cell Reports 2014;7:12-8. [DOI: 10.1016/j.celrep.2014.02.032] [Cited by in Crossref: 181] [Cited by in F6Publishing: 177] [Article Influence: 22.6] [Reference Citation Analysis]
494 Warmbrunn MV, Herrema H, Aron-Wisnewsky J, Soeters MR, Van Raalte DH, Nieuwdorp M. Gut microbiota: a promising target against cardiometabolic diseases. Expert Rev Endocrinol Metab 2020;15:13-27. [PMID: 32066294 DOI: 10.1080/17446651.2020.1720511] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
495 Popescu IR, Helleboid-Chapman A, Lucas A, Vandewalle B, Dumont J, Bouchaert E, Derudas B, Kerr-Conte J, Caron S, Pattou F, Staels B. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett 2010;584:2845-51. [PMID: 20447400 DOI: 10.1016/j.febslet.2010.04.068] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
496 Yang S, Li X, Yang F, Zhao R, Pan X, Liang J, Tian L, Li X, Liu L, Xing Y, Wu M. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target. Front Pharmacol 2019;10:1360. [PMID: 31803054 DOI: 10.3389/fphar.2019.01360] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 16.0] [Reference Citation Analysis]
497 Silveira MG, Lindor KD. Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis. Expert Opin Pharmacother. 2014;15:365-372. [PMID: 24382005 DOI: 10.1517/14656566.2014.873404] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
498 Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Cariou B, Kuipers F, Caron S, Staels B. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes. 2011;60:1861-1871. [PMID: 21593203 DOI: 10.2337/db11-0030] [Cited by in Crossref: 179] [Cited by in F6Publishing: 178] [Article Influence: 16.3] [Reference Citation Analysis]
499 Bladé C, Arola L, Salvadó MJ. Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms. Mol Nutr Food Res. 2010;54:37-59. [PMID: 19960459 DOI: 10.1002/mnfr.200900476] [Cited by in Crossref: 185] [Cited by in F6Publishing: 171] [Article Influence: 15.4] [Reference Citation Analysis]
500 Smith Z, Ryerson D, Kemper JK. Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors. Mol Cell Endocrinol 2013;368:59-70. [PMID: 22579755 DOI: 10.1016/j.mce.2012.04.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
501 Wei M, Shao Y, Liu QR, Wu QZ, Zhang X, Zhong MW, Liu SZ, Zhang GY, Hu SY. Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries. Am J Physiol Gastrointest Liver Physiol 2018;314:G537-46. [PMID: 29351394 DOI: 10.1152/ajpgi.00311.2017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
502 Morimoto K, Watanabe M, Sugizaki T, Irie J, Itoh H. Intestinal Bile Acid Composition Modulates Prohormone Convertase 1/3 (PC1/3) Expression and Consequent GLP-1 Production in Male Mice. Endocrinology 2016;157:1071-81. [PMID: 26789236 DOI: 10.1210/en.2015-1551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
503 Lucio M, Fekete A, Weigert C, Wägele B, Zhao X, Chen J, Fritsche A, Häring HU, Schleicher ED, Xu G, Schmitt-Kopplin P, Lehmann R. Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach. PLoS One 2010;5:e13317. [PMID: 20976215 DOI: 10.1371/journal.pone.0013317] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
504 Haeusler RA, Camastra S, Nannipieri M, Astiarraga B, Castro-Perez J, Xie D, Wang L, Chakravarthy M, Ferrannini E. Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity. J Clin Endocrinol Metab 2016;101:1935-44. [PMID: 26684275 DOI: 10.1210/jc.2015-2583] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 8.0] [Reference Citation Analysis]
505 Ha J, Kwon Y, Park S. Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes. Obes Surg 2021. [PMID: 34318371 DOI: 10.1007/s11695-021-05566-9] [Reference Citation Analysis]
506 Sombetzki M, Fuchs CD, Fickert P, Österreicher CH, Mueller M, Claudel T, Loebermann M, Engelmann R, Langner C, Sahin E. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis. J Hepatol. 2015;62:871-878. [PMID: 25463533 DOI: 10.1016/j.jhep.2014.11.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
507 McMahan RH, Wang XX, Cheng LL, Krisko T, Smith M, El Kasmi K, Pruzanski M, Adorini L, Golden-Mason L, Levi M, Rosen HR. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J Biol Chem. 2013;288:11761-11770. [PMID: 23460643 DOI: 10.1074/jbc.m112.446575] [Cited by in Crossref: 137] [Cited by in F6Publishing: 74] [Article Influence: 15.2] [Reference Citation Analysis]
508 Polyzos SA, Kountouras J, Mantzoros CS. Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns. Metabolism 2020;104:154144. [DOI: 10.1016/j.metabol.2020.154144] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
509 Radreau P, Porcherot M, Ramiére C, Mouzannar K, Lotteau V, André P. Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes. FASEB j 2016;30:3146-54. [DOI: 10.1096/fj.201500134] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
510 Naran S, Abrams P, de Oliveira PQ, Hughes SJ. Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis. J Surg Res 2011;171:504-9. [PMID: 20934723 DOI: 10.1016/j.jss.2010.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
511 Pathak P, Liu H, Boehme S, Xie C, Krausz KW, Gonzalez F, Chiang JYL. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. J Biol Chem 2017;292:11055-69. [PMID: 28478385 DOI: 10.1074/jbc.M117.784322] [Cited by in Crossref: 97] [Cited by in F6Publishing: 69] [Article Influence: 19.4] [Reference Citation Analysis]
512 Iyer GR, Wigginton J, Duren W, LaBarre JL, Brandenburg M, Burant C, Michailidis G, Karnovsky A. Application of Differential Network Enrichment Analysis for Deciphering Metabolic Alterations. Metabolites 2020;10:E479. [PMID: 33255384 DOI: 10.3390/metabo10120479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
513 Straniero S, Laskar A, Savva C, Härdfeldt J, Angelin B, Rudling M. Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism. J Lipid Res 2020;61:480-91. [PMID: 32086245 DOI: 10.1194/jlr.RA119000307] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
514 Xie S, Guo C, Chi Z, Huang B, Wu Y, Wang D, Xia D. A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism. FEBS Lett 2017;591:2836-47. [PMID: 28787755 DOI: 10.1002/1873-3468.12782] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
515 Lasalle M, Hoguet V, Hennuyer N, Leroux F, Piveteau C, Belloy L, Lestavel S, Vallez E, Dorchies E, Duplan I, Sevin E, Culot M, Gosselet F, Boulahjar R, Herledan A, Staels B, Deprez B, Tailleux A, Charton J. Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance. J Med Chem 2017;60:4185-211. [PMID: 28414465 DOI: 10.1021/acs.jmedchem.6b01873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
516 Roda A, Aldini R, Camborata C, Spinozzi S, Franco P, Cont M, D'Errico A, Vasuri F, Degiovanni A, Maroni L, Adorini L. Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis. Clin Transl Sci 2017;10:292-301. [PMID: 28411380 DOI: 10.1111/cts.12468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
517 Sheng L, Jena PK, Liu HX, Kalanetra KM, Gonzalez FJ, French SW, Krishnan VV, Mills DA, Wan YY. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation. Sci Rep. 2017;7:1748. [PMID: 28496104 DOI: 10.1038/s41598-017-01576-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
518 Asgharpour A, Kumar D, Sanyal A. Bile acids: emerging role in management of liver diseases. Hepatol Int. 2015;9:527-533. [PMID: 26320013 DOI: 10.1007/s12072-015-9656-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
519 Khurana S, Raufman JP, Pallone TL. Bile acids regulate cardiovascular function. Clin Transl Sci. 2011;4:210-218. [PMID: 21707953 DOI: 10.1111/j.1752-8062.2011.00272.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 7.4] [Reference Citation Analysis]
520 Noh K, Kim YM, Kim YW, Kim SG. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β. Drug Metab Dispos. 2011;39:1451-1459. [PMID: 21596890 DOI: 10.1124/dmd.111.038414] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
521 Venturoni F, Gioiello A, Sardella R, Natalini B, Pellicciari R. Continuous flow synthesis and scale-up of glycine- and taurine-conjugated bile salts. Org Biomol Chem 2012;10:4109. [DOI: 10.1039/c2ob25528f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
522 Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gómez-Lechón MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013;87:1315-530. [PMID: 23974980 DOI: 10.1007/s00204-013-1078-5] [Cited by in Crossref: 751] [Cited by in F6Publishing: 687] [Article Influence: 83.4] [Reference Citation Analysis]
523 Baumgartner S, Reijnders D, Konings MCJM, Groen AK, Lütjohann D, Goossens GH, Blaak EE, Plat J. The effects of amoxicillin and vancomycin on parameters reflecting cholesterol metabolism. Chem Phys Lipids 2017;207:239-45. [PMID: 28647339 DOI: 10.1016/j.chemphyslip.2017.06.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
524 De Fabiani E, Mitro N, Gilardi F, Crestani M. Sterol-protein interactions in cholesterol and bile acid synthesis. Subcell Biochem 2010;51:109-35. [PMID: 20213542 DOI: 10.1007/978-90-481-8622-8_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
525 Kim K, Sandoval DA. Endocrine Function after Bariatric Surgery. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 783-98. [DOI: 10.1002/cphy.c160019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
526 Benhamed F, Filhoulaud G, Caron S, Lefebvre P, Staels B, Postic C. O-GlcNAcylation Links ChREBP and FXR to Glucose-Sensing. Front Endocrinol (Lausanne) 2014;5:230. [PMID: 25628602 DOI: 10.3389/fendo.2014.00230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
527 Kemper JK. Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications. Biochim Biophys Acta. 2011;1812:842-850. [PMID: 21130162 DOI: 10.1016/j.bbadis.2010.11.011] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
528 Alawad AS, Levy C. FXR Agonists: From Bench to Bedside, a Guide for Clinicians. Dig Dis Sci 2016;61:3395-404. [DOI: 10.1007/s10620-016-4334-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
529 Bhargava P, Li C, Stanya KJ, Jacobi D, Dai L, Liu S, Gangl MR, Harn DA, Lee CH. Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med. 2012;18:1665-1672. [PMID: 23104131 DOI: 10.1038/nm.2962] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 8.3] [Reference Citation Analysis]
530 Ibrahim S, Dayoub R, Krautbauer S, Liebisch G, Wege AK, Melter M, Weiss TS. Bile acid-induced apoptosis and bile acid synthesis are reduced by over-expression of Augmenter of Liver Regeneration (ALR) in a STAT3-dependent mechanism. Experimental Cell Research 2019;374:189-97. [DOI: 10.1016/j.yexcr.2018.11.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
531 Khatib M, Zvibel I, Zelber-Sagi S, Varol C, Lahat G, Abu-Abeid S, Klausner JM, Halpern Z, Fishman S. Discriminatory metabolic and inflammatory parameters in serum and omental adipose tissue of obese patients with different insulin sensitivity. J Clin Transl Endocrinol 2014;1:115-9. [PMID: 29159092 DOI: 10.1016/j.jcte.2014.07.005] [Reference Citation Analysis]
532 Huang HH, Lee WJ, Chen SC, Chen TF, Lee SD, Chen CY. Bile Acid and Fibroblast Growth Factor 19 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Sleeve Gastrectomy. J Clin Med. 2019;8:pii: E815. [PMID: 31181641 DOI: 10.3390/jcm8060815] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
533 Baptissart M, Vega A, Martinot E, Pommier AJ, Houten SM, Marceau G, de Haze A, Baron S, Schoonjans K, Lobaccaro JM, Volle DH. Bile acids alter male fertility through G-protein-coupled bile acid receptor 1 signaling pathways in mice. Hepatology 2014;60:1054-65. [PMID: 24798773 DOI: 10.1002/hep.27204] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
534 Alex S, Lichtenstein L, Dijk W, Mensink RP, Tan NS, Kersten S. ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract. Histochem Cell Biol 2014;141:383-91. [DOI: 10.1007/s00418-013-1157-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
535 Xie Z, Jiang H, Liu W, Zhang X, Chen D, Sun S, Zhou C, Liu J, Bao S, Wang X, Zhang Y, Li J, Hu L, Li J. The triterpenoid sapogenin (2α-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling. Cell Death Dis 2020;11:770. [PMID: 32943612 DOI: 10.1038/s41419-020-02974-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
536 Chiang JYL, Ferrell JM. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Res 2020;4:47-63. [PMID: 34290896 DOI: 10.1016/j.livres.2020.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
537 Jahn D, Rau M, Hermanns HM, Geier A. Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease. Cytokine & Growth Factor Reviews 2015;26:625-35. [DOI: 10.1016/j.cytogfr.2015.07.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
538 Pockros PJ, Fuchs M, Freilich B, Schiff E, Kohli A, Lawitz EJ, Hellstern PA, Owens-Grillo J, Van Biene C, Shringarpure R, MacConell L, Shapiro D, Cohen DE. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. Liver Int 2019;39:2082-93. [PMID: 31402538 DOI: 10.1111/liv.14209] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
539 Hageman J, Herrema H, Groen AK, Kuipers F. A role of the bile salt receptor FXR in atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:1519-1528. [PMID: 20631352 DOI: 10.1161/atvbaha.109.197897] [Cited by in Crossref: 62] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
540 Kumar AA, Satheesh G, Vijayakumar G, Chandran M, Prabhu PR, Simon L, Kutty VR, Kartha CC, Jaleel A. Plasma leptin level mirrors metabolome alterations in young adults. Metabolomics 2020;16:87. [PMID: 32772182 DOI: 10.1007/s11306-020-01708-9] [Reference Citation Analysis]
541 Dieleman S, Aarnoutse R, Ziemons J, Kooreman L, Boleij A, Smidt M. Exploring the Potential of Breast Microbiota as Biomarker for Breast Cancer and Therapeutic Response. Am J Pathol 2021;191:968-82. [PMID: 33713687 DOI: 10.1016/j.ajpath.2021.02.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
542 Hui S, Liu Y, Chen M, Wang X, Lang H, Zhou M, Yi L, Mi M. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota‐Bile Acid‐FXR Axis in Type 2 Diabetic db/db Mice. Mol Nutr Food Res 2019;63:1900608. [DOI: 10.1002/mnfr.201900608] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
543 Frisch K, Stimson DHR, Venkatachalam T, Pierens GK, Keiding S, Reutens D, Bhalla R. N-(4-[18F]fluorobenzyl)cholylglycine, a novel tracer for PET of enterohepatic circulation of bile acids: Radiosynthesis and proof-of-concept studies in rats. Nucl Med Biol 2018;61:56-62. [PMID: 29783201 DOI: 10.1016/j.nucmedbio.2018.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
544 Lacroix IM, Li-Chan EC. Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes. Mol Nutr Food Res 2014;58:61-78. [PMID: 23943383 DOI: 10.1002/mnfr.201300223] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
545 Pushpass RG, Alzoufairi S, Jackson KG, Lovegrove JA. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods. Nutr Res Rev 2021;:1-20. [PMID: 33926590 DOI: 10.1017/S0954422421000081] [Reference Citation Analysis]
546 Fujii O, Tatsumi S, Ogata M, Arakaki T, Sakaguchi H, Nomura K, Miyagawa A, Ikuta K, Hanazaki A, Kaneko I, Segawa H, Miyamoto KI. Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone-Kidney-Gut Axis. Front Endocrinol (Lausanne) 2017;8:359. [PMID: 29312149 DOI: 10.3389/fendo.2017.00359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
547 Gerlini R, Berti L, Darr J, Lassi M, Brandmaier S, Fritsche L, Scheid F, Böhm A, Königsrainer A, Grallert H, Häring HU, Hrabě de Angelis M, Staiger H, Teperino R. Glucose tolerance and insulin sensitivity define adipocyte transcriptional programs in human obesity. Mol Metab 2018;18:42-50. [PMID: 30309776 DOI: 10.1016/j.molmet.2018.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
548 Dergunov AD. Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: mechanistic and clinical studies. Biomed Pharmacother. 2011;65:597-603. [PMID: 21705182 DOI: 10.1016/j.biopha.2011.04.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
549 Poole DP, Godfrey C, Cattaruzza F, Cottrell GS, Kirkland JG, Pelayo JC, Bunnett NW, Corvera CU. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil. 2010;22:814-825, e227-228. [PMID: 20236244 DOI: 10.1111/j.1365-2982.2010.01487.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 136] [Article Influence: 11.4] [Reference Citation Analysis]
550 Branchereau M, Burcelin R, Heymes C. The gut microbiome and heart failure: A better gut for a better heart. Rev Endocr Metab Disord 2019;20:407-14. [PMID: 31705258 DOI: 10.1007/s11154-019-09519-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
551 Bartley GE, Yokoyama W, Young SA, Anderson WHK, Hung S, Albers DR, Langhorst ML, Kim H. Hypocholesterolemic Effects of Hydroxypropyl Methylcellulose Are Mediated by Altered Gene Expression in Hepatic Bile and Cholesterol Pathways of Male Hamsters. The Journal of Nutrition 2010;140:1255-60. [DOI: 10.3945/jn.109.118349] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
552 Cave MC, Clair HB, Hardesty JE, Falkner KC, Feng W, Clark BJ, Sidey J, Shi H, Aqel BA, McClain CJ. Nuclear receptors and nonalcoholic fatty liver disease. Biochim Biophys Acta. 2016;1859:1083-1099. [PMID: 26962021 DOI: 10.1016/j.bbagrm.2016.03.002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 121] [Article Influence: 21.0] [Reference Citation Analysis]
553 Mo Y, Sun H, Zhang L, Geng W, Wang L, Zou C, Wu Y, Ji C, Liu X, Lu Z. Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of α-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats. Front Pharmacol 2021;12:657827. [PMID: 34045965 DOI: 10.3389/fphar.2021.657827] [Reference Citation Analysis]
554 Li T, Chiang JY. Bile Acid signaling in liver metabolism and diseases. J Lipids. 2012;2012:754067. [PMID: 21991404 DOI: 10.1155/2012/754067] [Cited by in Crossref: 61] [Cited by in F6Publishing: 78] [Article Influence: 5.5] [Reference Citation Analysis]
555 Nagahashi M, Takabe K, Liu R, Peng K, Wang X, Wang Y, Hait NC, Wang X, Allegood JC, Yamada A, Aoyagi T, Liang J, Pandak WM, Spiegel S, Hylemon PB, Zhou H. Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology. 2015;61:1216-1226. [PMID: 25363242 DOI: 10.1002/hep.27592] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 13.3] [Reference Citation Analysis]
556 Chávez-Talavera O, Baud G, Spinelli V, Daoudi M, Kouach M, Goossens JF, Vallez E, Caiazzo R, Ghunaim M, Hubert T, Lestavel S, Tailleux A, Staels B, Pattou F. Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs. Int J Obes (Lond) 2017;41:664-8. [PMID: 28093571 DOI: 10.1038/ijo.2017.7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
557 Fu J, Yu M, Xu W, Yu S. Research Progress of Bile Acids in Cancer. Front Oncol 2022;11:778258. [DOI: 10.3389/fonc.2021.778258] [Reference Citation Analysis]
558 Pardee K, Necakov AS, Krause H. Nuclear Receptors: Small Molecule Sensors that Coordinate Growth, Metabolism and Reproduction. Subcell Biochem 2011;52:123-53. [PMID: 21557081 DOI: 10.1007/978-90-481-9069-0_6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
559 Li M, Hu X, Xu Y, Hu X, Zhang C, Pang S. A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models. Int J Endocrinol 2019;2019:3248527. [PMID: 31737069 DOI: 10.1155/2019/3248527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
560 Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 2011;140:1934-42. [PMID: 21396369 DOI: 10.1053/j.gastro.2011.02.063] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
561 Staels B, Handelsman Y, Fonseca V. Bile acid sequestrants for lipid and glucose control. Curr Diab Rep 2010;10:70-7. [PMID: 20425070 DOI: 10.1007/s11892-009-0087-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
562 Li T, Francl JM, Boehme S, Ochoa A, Zhang Y, Klaassen CD, Erickson SK, Chiang JY. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem. 2012;287:1861-1873. [PMID: 22144677 DOI: 10.1074/jbc.m111.305789] [Cited by in Crossref: 135] [Cited by in F6Publishing: 73] [Article Influence: 12.3] [Reference Citation Analysis]
563 Niu M, Tan Y, Guan P, Hovgaard L, Lu Y, Qi J, Lian R, Li X, Wu W. Enhanced oral absorption of insulin-loaded liposomes containing bile salts: A mechanistic study. International Journal of Pharmaceutics 2014;460:119-30. [DOI: 10.1016/j.ijpharm.2013.11.028] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 10.3] [Reference Citation Analysis]
564 Ferbeyre G. Bile acids in the fountain of youth. Aging (Albany NY) 2010;2:383-4. [PMID: 20622264 DOI: 10.18632/aging.100169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
565 Peeters A, Swinnen JV, Van Veldhoven PP, Baes M. Hepatosteatosis in peroxisome deficient liver despite increased β-oxidation capacity and impaired lipogenesis. Biochimie 2011;93:1828-38. [PMID: 21756965 DOI: 10.1016/j.biochi.2011.06.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
566 Lee WS, Jung JH, Panchanathan R, Yun JW, Kim DH, Kim HJ, Kim GS, Ryu CH, Shin SC, Hong SC, Choi YH, Jung JM. Ursodeoxycholic Acid Induces Death Receptor-mediated Apoptosis in Prostate Cancer Cells. J Cancer Prev 2017;22:16-21. [PMID: 28382282 DOI: 10.15430/JCP.2017.22.1.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
567 Cortés V, Amigo L, Zanlungo S, Galgani J, Robledo F, Arrese M, Bozinovic F, Nervi F. Metabolic effects of cholecystectomy: gallbladder ablation increases basal metabolic rate through G-protein coupled bile acid receptor Gpbar1-dependent mechanisms in mice. PLoS One 2015;10:e0118478. [PMID: 25738495 DOI: 10.1371/journal.pone.0118478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
568 Wei X, Yao T, Fall FN, Xue M, Liang X, Wang J, Du W, Gu X. An Integrated Bile Acids Profile Determination by UHPLC-MS/MS to Identify the Effect of Bile Acids Supplement in High Plant Protein Diet on Common Carp (Cyprinus carpio). Foods 2021;10:2465. [PMID: 34681514 DOI: 10.3390/foods10102465] [Reference Citation Analysis]
569 Trauner M, Fuchs CD. Novel therapeutic targets for cholestatic and fatty liver disease. Gut 2022;71:194-209. [PMID: 34615727 DOI: 10.1136/gutjnl-2021-324305] [Reference Citation Analysis]
570 Hersoug L, Møller P, Loft S. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity. Nutr Res Rev 2018;31:153-63. [DOI: 10.1017/s0954422417000269] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
571 Hansen M, Sonne DP, Knop FK. Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes. Curr Diab Rep. 2014;14:482. [PMID: 24623198 DOI: 10.1007/s11892-014-0482-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
572 Sabbatini P, Filipponi P, Sardella R, Natalini B, Nuti R, Macchiarulo A, Pellicciari R, Gioiello A. Synthesis and quantitative structure-property relationships of side chain-modified hyodeoxycholic acid derivatives. Molecules 2013;18:10497-513. [PMID: 23999724 DOI: 10.3390/molecules180910497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
573 Liu P, Xu X, Chen L, Ma L, Shen X, Hu L. Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists. Bioorg Med Chem 2014;22:1596-607. [PMID: 24513188 DOI: 10.1016/j.bmc.2014.01.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
574 Miura T, Tachikawa M, Ohtsuka H, Fukase K, Nakayama S, Sakata N, Motoi F, Naitoh T, Katayose Y, Uchida Y, Ohtsuki S, Terasaki T, Unno M. Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration. Journal of Pharmaceutical Sciences 2017;106:2499-508. [DOI: 10.1016/j.xphs.2017.02.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
575 Medkour Y, Dakik P, McAuley M, Mohammad K, Mitrofanova D, Titorenko VI. Mechanisms Underlying the Essential Role of Mitochondrial Membrane Lipids in Yeast Chronological Aging. Oxid Med Cell Longev 2017;2017:2916985. [PMID: 28593023 DOI: 10.1155/2017/2916985] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
576 Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corno C, Pini A, Adorini L, Vannelli GB, Maggi M, Vignozzi L. Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model. J Endocrinol Invest 2019;42:283-94. [PMID: 29923060 DOI: 10.1007/s40618-018-0913-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
577 Liu L, Yang M, Dong W, Liu T, Song X, Gu Y, Wang S, Liu Y, Abla Z, Qiao X, Liu W, Jiang K, Wang B, Zhang J, Cao H. Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer. Gastroenterol Res Pract 2021;2021:6645970. [PMID: 33708251 DOI: 10.1155/2021/6645970] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
578 Agnoux AM, Antignac J, Simard G, Poupeau G, Darmaun D, Parnet P, Alexandre-gouabau M. Time window-dependent effect of perinatal maternal protein restriction on insulin sensitivity and energy substrate oxidation in adult male offspring. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2014;307:R184-97. [DOI: 10.1152/ajpregu.00015.2014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
579 Berrabah W, Aumercier P, Gheeraert C, Dehondt H, Bouchaert E, Alexandre J, Ploton M, Mazuy C, Caron S, Tailleux A, Eeckhoute J, Lefebvre T, Staels B, Lefebvre P. Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR). Hepatology 2014;59:2022-33. [PMID: 24037988 DOI: 10.1002/hep.26710] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
580 Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, Edwards PA, Hazen SL, Lusis AJ. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49-60. [PMID: 23312283 DOI: 10.1016/j.cmet.2012.12.011] [Cited by in Crossref: 508] [Cited by in F6Publishing: 486] [Article Influence: 56.4] [Reference Citation Analysis]
581 van de Peppel IP, Doktorova M, Berkers G, de Jonge HR, Houwen RHJ, Verkade HJ, Jonker JW, Bodewes FAJA. IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation. J Cyst Fibros 2019;18:286-93. [PMID: 30279125 DOI: 10.1016/j.jcf.2018.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
582 Fickert P, Fuchsbichler A, Moustafa T, Wagner M, Zollner G, Halilbasic E, Stöger U, Arrese M, Pizarro M, Solís N, Carrasco G, Caligiuri A, Sombetzki M, Reisinger E, Tsybrovskyy O, Zatloukal K, Denk H, Jaeschke H, Pinzani M, Trauner M. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 2009;175:2392-405. [PMID: 19910507 DOI: 10.2353/ajpath.2009.090114] [Cited by in Crossref: 108] [Cited by in F6Publishing: 108] [Article Influence: 8.3] [Reference Citation Analysis]
583 Jain AK, le Roux CW, Puri P, Tavakkoli A, Gletsu-Miller N, Laferrère B, Kellermayer R, DiBaise JK, Martindale RG, Wolfe BM. Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut. JPEN J Parenter Enteral Nutr 2018;42:279-95. [PMID: 29443403 DOI: 10.1002/jpen.1121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
584 André P, Ramière C, Scholtes C, Curtil C, Lotteau V. Role of nuclear receptors in hepatitis B and C infections. Clinics and Research in Hepatology and Gastroenterology 2011;35:169-75. [DOI: 10.1016/j.clinre.2011.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
585 Cortés VA, Barrera F, Nervi F. Pathophysiological connections between gallstone disease, insulin resistance, and obesity. Obes Rev 2020;21:e12983. [PMID: 31814283 DOI: 10.1111/obr.12983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
586 Yamamoto S, Sato I, Fukuhama N, Akiyama N, Sakai M, Kumazaki S, Ran S, Hirohata S, Kitamori K, Yamori Y, Watanabe S. Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model. Exp Mol Pathol 2020;114:104437. [PMID: 32246926 DOI: 10.1016/j.yexmp.2020.104437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
587 Ramírez-Pérez O, Cruz-Ramón V, Chinchilla-López P, Méndez-Sánchez N. The Role of the Gut Microbiota in Bile Acid Metabolism. Ann Hepatol 2017;16:s15-20. [PMID: 29080339 DOI: 10.5604/01.3001.0010.5494] [Cited by in Crossref: 29] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
588 Chhatwal P, Bankwitz D, Gentzsch J, Frentzen A, Schult P, Lohmann V, Pietschmann T. Bile acids specifically increase hepatitis C virus RNA-replication. PLoS One 2012;7:e36029. [PMID: 22558311 DOI: 10.1371/journal.pone.0036029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
589 van Zutphen T, Stroeve JHM, Yang J, Bloks VW, Jurdzinski A, Roelofsen H, Huijkman NCA, van Dijk TH, Vonk RJ, van Deursen J, Staels B, Groen AK, Kuipers F. FXR overexpression alters adipose tissue architecture in mice and limits its storage capacity leading to metabolic derangements. J Lipid Res 2019;60:1547-61. [PMID: 31253637 DOI: 10.1194/jlr.M094508] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
590 Macchiarulo A, Gioiello A, Thomas C, Pols TW, Nuti R, Ferrari C, Giacchè N, De Franco F, Pruzanski M, Auwerx J, Schoonjans K, Pellicciari R. Probing the Binding Site of Bile Acids in TGR5. ACS Med Chem Lett 2013;4:1158-62. [PMID: 24900622 DOI: 10.1021/ml400247k] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
591 Tang WHW, Li DY, Hazen SL. Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol 2019;16:137-54. [PMID: 30410105 DOI: 10.1038/s41569-018-0108-7] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 73.0] [Reference Citation Analysis]
592 Chen M, Jin Y, Penning TM. In-Depth Dissection of the P133R Mutation in Steroid 5β-Reductase (AKR1D1): A Molecular Basis of Bile Acid Deficiency. Biochemistry 2015;54:6343-51. [PMID: 26418565 DOI: 10.1021/acs.biochem.5b00816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
593 Ting TC, Miyazaki-Anzai S, Masuda M, Levi M, Demer LL, Tintut Y, Miyazaki M. Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem 2011;286:23938-49. [PMID: 21596756 DOI: 10.1074/jbc.M111.237065] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
594 Li T, Chiang JY. Nuclear receptors in bile acid metabolism. Drug Metab Rev. 2013;45:145-155. [PMID: 23330546 DOI: 10.3109/03602532.2012.740048] [Cited by in Crossref: 100] [Cited by in F6Publishing: 97] [Article Influence: 11.1] [Reference Citation Analysis]
595 Garcia M, Thirouard L, Sedès L, Monrose M, Holota H, Caira F, Volle DH, Beaudoin C. Nuclear Receptor Metabolism of Bile Acids and Xenobiotics: A Coordinated Detoxification System with Impact on Health and Diseases. Int J Mol Sci 2018;19:E3630. [PMID: 30453651 DOI: 10.3390/ijms19113630] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
596 Jensen DD, Godfrey CB, Niklas C, Canals M, Kocan M, Poole DP, Murphy JE, Alemi F, Cottrell GS, Korbmacher C, Lambert NA, Bunnett NW, Corvera CU. The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J Biol Chem 2013;288:22942-60. [PMID: 23818521 DOI: 10.1074/jbc.M113.455774] [Cited by in Crossref: 67] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
597 Miyata M, Matsushita K, Shindo R, Shimokawa Y, Sugiura Y, Yamashita M. Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD. Nutrients 2020;12:E1898. [PMID: 32604760 DOI: 10.3390/nu12061898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
598 Tian Y, Cai J, Gui W, Nichols RG, Koo I, Zhang J, Anitha M, Patterson AD. Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation. Drug Metab Dispos. 2019;47:86-93. [PMID: 30409838 DOI: 10.1124/dmd.118.083691] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
599 Jadeja RN, Thounaojam MC, Bartoli M, Khurana S. Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by attenuating Ca2+ sensitivity via rho kinase pathway. Toxicol Appl Pharmacol 2018;348:14-21. [PMID: 29660437 DOI: 10.1016/j.taap.2018.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
600 Chen M, Wangtrakuldee P, Zang T, Duan L, Gathercole LL, Tomlinson JW, Penning TM. Human and murine steroid 5β-reductases (AKR1D1 and AKR1D4): insights into the role of the catalytic glutamic acid. Chem Biol Interact 2019;305:163-70. [PMID: 30928400 DOI: 10.1016/j.cbi.2019.03.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
601 Thompson JS, Weseman RA, Rochling FA, Lyden E, Grant WJ, Vargas LM, Langnas AN, Mercer DF. Cholecystectomy and Liver Disease in Short Bowel Syndrome. J Gastrointest Surg 2016;20:322-7. [DOI: 10.1007/s11605-015-3008-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
602 Herz CT, Kulterer OC, Prager M, Langer FB, Prager G, Marculescu R, Fauler G, Hacker M, Kautzky-Willer A, Trauner M, Haug AR, Kiefer FW. Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue. Mol Cell Endocrinol 2021;536:111403. [PMID: 34332024 DOI: 10.1016/j.mce.2021.111403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
603 Yu EA, Yu T, Jones DP, Ramirez-Zea M, Stein AD. Metabolomic Profiling After a Meal Shows Greater Changes and Lower Metabolic Flexibility in Cardiometabolic Diseases. J Endocr Soc 2020;4:bvaa127. [PMID: 33134764 DOI: 10.1210/jendso/bvaa127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
604 Stenman LK, Holma R, Gylling H, Korpela R. Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity. Br J Nutr 2013;110:1157-64. [PMID: 23442231 DOI: 10.1017/S000711451300024X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
605 Evangelakos I, Heeren J, Verkade E, Kuipers F. Role of bile acids in inflammatory liver diseases. Semin Immunopathol 2021. [PMID: 34236487 DOI: 10.1007/s00281-021-00869-6] [Reference Citation Analysis]
606 Ijssennagger N, Janssen AWF, Milona A, Ramos Pittol JM, Hollman DAA, Mokry M, Betzel B, Berends FJ, Janssen IM, van Mil SWC, Kersten S. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid. J Hepatol 2016;64:1158-66. [PMID: 26812075 DOI: 10.1016/j.jhep.2016.01.016] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 9.5] [Reference Citation Analysis]
607 Ziętak M, Chabowska-kita A, Kozak LP. Brown fat thermogenesis: Stability of developmental programming and transient effects of temperature and gut microbiota in adults. Biochimie 2017;134:93-8. [DOI: 10.1016/j.biochi.2016.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
608 Palau-Rodriguez M, Tulipani S, Isabel Queipo-Ortuño M, Urpi-Sarda M, Tinahones FJ, Andres-Lacueva C. Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Front Microbiol 2015;6:1151. [PMID: 26579078 DOI: 10.3389/fmicb.2015.01151] [Cited by in F6Publishing: 62] [Reference Citation Analysis]
609 Salze GP, Davis DA. Taurine: a critical nutrient for future fish feeds. Aquaculture 2015;437:215-29. [DOI: 10.1016/j.aquaculture.2014.12.006] [Cited by in Crossref: 171] [Cited by in F6Publishing: 71] [Article Influence: 24.4] [Reference Citation Analysis]
610 Smelt AH. Triglycerides and gallstone formation. Clin Chim Acta. 2010;411:1625-1631. [PMID: 20699090 DOI: 10.1016/j.cca.2010.08.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
611 Di Ciaula A, Stella A, Bonfrate L, Wang DQH, Portincasa P. Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF). Genes (Basel) 2020;11:E1041. [PMID: 32899315 DOI: 10.3390/genes11091041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
612 Jonsson AL, Bäckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 2017;14:79-87. [PMID: 27905479 DOI: 10.1038/nrcardio.2016.183] [Cited by in Crossref: 192] [Cited by in F6Publishing: 181] [Article Influence: 32.0] [Reference Citation Analysis]
613 Ibrahim S, Dayoub R, Melter M, Weiss TS. Bile acids down-regulate the expression of Augmenter of Liver Regeneration (ALR) via SHP/HNF4α1 and independent of Egr-1. Experimental and Molecular Pathology 2018;105:236-42. [DOI: 10.1016/j.yexmp.2018.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
614 Xu Y, Li F, Zalzala M, Xu J, Gonzalez FJ, Adorini L, Lee YK, Yin L, Zhang Y. Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology 2016;64:1072-85. [PMID: 27359351 DOI: 10.1002/hep.28712] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
615 Masaoutis C, Theocharis S. The farnesoid X receptor: a potential target for expanding the therapeutic arsenal against kidney disease. Expert Opin Ther Targets 2019;23:107-16. [PMID: 30577722 DOI: 10.1080/14728222.2019.1559825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
616 Thompson JS, Mercer DF, Vargas LM, Grant WJ, Rochling FA, Langnas AN. Prophylactic cholecystectomy in short bowel syndrome: Is it being utilized? The American Journal of Surgery 2018;216:73-7. [DOI: 10.1016/j.amjsurg.2018.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
617 Thuy VTT, Lim CW, Park JH, Ahn C, Kim D. Self-assembled nanoaggregates based on polyaspartamide graft copolymers for pH-controlled release of doxorubicin. J Mater Chem B 2015;3:2978-85. [DOI: 10.1039/c4tb01930j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
618 Rizzo G, Passeri D, De Franco F, Ciaccioli G, Donadio L, Rizzo G, Orlandi S, Sadeghpour B, Wang XX, Jiang T, Levi M, Pruzanski M, Adorini L. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist. Mol Pharmacol. 2010;78:617-630. [PMID: 20631053 DOI: 10.1124/mol.110.064501] [Cited by in Crossref: 118] [Cited by in F6Publishing: 117] [Article Influence: 9.8] [Reference Citation Analysis]
619 Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B. 2015;5:135-144. [PMID: 26579439 DOI: 10.1016/j.apsb.2015.01.004] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 19.0] [Reference Citation Analysis]
620 Li Q, Larouche-Lebel É, Loughran KA, Huh TP, Suchodolski JS, Oyama MA. Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease. mSystems 2021;6:e00111-21. [PMID: 33879495 DOI: 10.1128/mSystems.00111-21] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
621 Freeman JS. Review of insulin-dependent and insulin-independent agents for treating patients with type 2 diabetes mellitus and potential role for sodium-glucose co-transporter 2 inhibitors. Postgrad Med 2013;125:214-26. [PMID: 23748522 DOI: 10.3810/pgm.2013.05.2672] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
622 Mohanty A, McBride HM. Emerging roles of mitochondria in the evolution, biogenesis, and function of peroxisomes. Front Physiol. 2013;4:268. [PMID: 24133452 DOI: 10.3389/fphys.2013.00268] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
623 Lee FY, de Aguiar Vallim TQ, Chong HK, Zhang Y, Liu Y, Jones SA, Osborne TF, Edwards PA. Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity. Mol Endocrinol. 2010;24:1626-1636. [PMID: 20573685 DOI: 10.1210/me.2010-0117] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
624 Sonne DP, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1. European Journal of Endocrinology 2014;171:407-19. [DOI: 10.1530/eje-14-0309] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 4.6] [Reference Citation Analysis]
625 Acharya P, Talahalli RR. n-3 Fatty Acids Abrogate Dyslipidemia-Induced Changes in Bile Acid Uptake, Synthesis, and Transport in Young and Aged Dyslipidemic Rats. Lipids 2019;54:39-51. [DOI: 10.1002/lipd.12125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
626 Gora AH, Rehman S, Kiron V, Dias J, Fernandes JMO, Olsvik PA, Siriyappagouder P, Vatsos I, Schmid-staiger U, Frick K, Cardoso M. Management of Hypercholesterolemia Through Dietary ß-glucans–Insights From a Zebrafish Model. Front Nutr 2022;8:797452. [DOI: 10.3389/fnut.2021.797452] [Reference Citation Analysis]
627 Dwivedi SK, Singh N, Kumari R, Mishra JS, Tripathi S, Banerjee P, Shah P, Kukshal V, Tyagi AM, Gaikwad AN, Chaturvedi RK, Mishra DP, Trivedi AK, Sanyal S, Chattopadhyay N, Ramachandran R, Siddiqi MI, Bandyopadhyay A, Arora A, Lundåsen T, Anakk SP, Moore DD, Sanyal S. Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α. Mol Endocrinol 2011;25:922-32. [PMID: 21493670 DOI: 10.1210/me.2010-0512] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
628 Osuna-Prieto FJ, Rubio-Lopez J, Di X, Yang W, Kohler I, Rensen PCN, Ruiz JR, Martinez-Tellez B. Plasma levels of bile acids are related to cardiometabolic risk factors in young adults. J Clin Endocrinol Metab 2021:dgab773. [PMID: 34718617 DOI: 10.1210/clinem/dgab773] [Reference Citation Analysis]
629 Liu Y, Shi D, Tian Y, Liu Y, Zhan Q, Xu J, Wang J, Xue C. Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease. Lipids 2017;52:119-27. [DOI: 10.1007/s11745-016-4222-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
630 Hodge RJ, Lin J, Vasist Johnson LS, Gould EP, Bowers GD, Nunez DJ; SB-756050 Project Team. Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes. Clin Pharmacol Drug Dev 2013;2:213-22. [PMID: 27121782 DOI: 10.1002/cpdd.34] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
631 Ben-Shlomo S, Zvibel I, Rabinowich L, Goldiner I, Shlomai A, Santo EM, Halpern Z, Oren R, Fishman S. Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis. Dig Dis Sci. 2013;58:172-178. [PMID: 22918684 DOI: 10.1007/s10620-012-2353-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
632 Sun Z, Huang C, Shi Y, Wang R, Fan J, Yu Y, Zhang Z, Zhu K, Li M, Ni Q, Chen Z, Zheng M, Yang Z. Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome. Front Med (Lausanne) 2021;8:708495. [PMID: 34671614 DOI: 10.3389/fmed.2021.708495] [Reference Citation Analysis]
633 Kida T, Omori K, Hori M, Ozaki H, Murata T. Stimulation of G Protein–Coupled Bile Acid Receptor Enhances Vascular Endothelial Barrier Function via Activation of Protein Kinase A and Rac1. J Pharmacol Exp Ther 2013;348:125-30. [DOI: 10.1124/jpet.113.209288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
634 Xie C, Takahashi S, Brocker CN, He S, Chen L, Xie G, Jang K, Gao X, Krausz KW, Qu A, Levi M, Gonzalez FJ. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport. Biochim Biophys Acta Mol Cell Biol Lipids 2019;1864:1396-411. [PMID: 31195146 DOI: 10.1016/j.bbalip.2019.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
635 Out C, Groen AK, Brufau G. Bile acid sequestrants: more than simple resins. Curr Opin Lipidol 2012;23:43-55. [PMID: 22186660 DOI: 10.1097/MOL.0b013e32834f0ef3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
636 Quintero P, Pizarro M, Solís N, Arab JP, Padilla O, Riquelme A, Arrese M. Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. J Physiol Biochem 2014;70:667-74. [DOI: 10.1007/s13105-014-0336-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
637 Shen J, Arnett DK, Parnell LD, Lai CQ, Straka RJ, Hopkins PN, An P, Feitosa MF, Ordovás JM. The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate. J Cardiovasc Pharmacol. 2012;59:254-259. [PMID: 22075751 DOI: 10.1097/FJC.0b013e31823de86b] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
638 Li S, Hua D, Wang Q, Yang L, Wang X, Luo A, Yang C. The Role of Bacteria and Its Derived Metabolites in Chronic Pain and Depression: Recent Findings and Research Progress. Int J Neuropsychopharmacol 2020;23:26-41. [PMID: 31760425 DOI: 10.1093/ijnp/pyz061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
639 Lee E, Lee D, Kim H, Ahn S, Seong H, Jung WH, Kim KY, Kim S, Rhee SD. Cyp7a1 is continuously increased with disrupted Fxr-mediated feedback inhibition in hypercholesterolemic TALLYHO/Jng mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018;1863:20-5. [DOI: 10.1016/j.bbalip.2017.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
640 Carr RM, Correnti J. Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci. 2015;1353:1-20. [PMID: 25998863 DOI: 10.1111/nyas.12787] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
641 Marina AL, Utzschneider KM, Wright LA, Montgomery BK, Marcovina SM, Kahn SE. Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and β-cell function. Diabetes Care 2012;35:1119-25. [PMID: 22446171 DOI: 10.2337/dc11-2050] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
642 Jiang L, Schnabl B. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Physiology (Bethesda) 2020;35:261-74. [PMID: 32490750 DOI: 10.1152/physiol.00005.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
643 Beysen C, Murphy EJ, Deines K, Chan M, Tsang E, Glass A, Turner SM, Protasio J, Riiff T, Hellerstein MK. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study. Diabetologia 2012;55:432-42. [PMID: 22134839 DOI: 10.1007/s00125-011-2382-3] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 8.8] [Reference Citation Analysis]
644 Prawitt J, Caron S, Staels B. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization. Trends Endocrinol Metab 2014;25:235-44. [PMID: 24731596 DOI: 10.1016/j.tem.2014.03.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
645 Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Lonardo A. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Adv Ther 2016;33:291-319. [DOI: 10.1007/s12325-016-0306-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
646 Wewalka M, Patti ME, Barbato C, Houten SM, Goldfine AB. Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. J Clin Endocrinol Metab. 2014;99:1442-1451. [PMID: 24432996 DOI: 10.1210/jc.2013-3367] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 9.5] [Reference Citation Analysis]
647 Zaborska KE, Lee SA, Garribay D, Cha E, Cummings BP. Deoxycholic acid supplementation impairs glucose homeostasis in mice. PLoS One 2018;13:e0200908. [PMID: 30059528 DOI: 10.1371/journal.pone.0200908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
648 Natalini B, Sardella R, Gioiello A, Rosatelli E, Ianni F, Camaioni E, Pellicciari R. Fast chromatographic determination of the bile salt critical micellar concentration. Anal Bioanal Chem 2011;401:267-74. [DOI: 10.1007/s00216-011-5082-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
649 Ferrannini E, Camastra S, Astiarraga B, Nannipieri M, Castro-Perez J, Xie D, Wang L, Chakravarthy M, Haeusler RA. Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion. Diabetes. 2015;64:3377-3385. [PMID: 26015549 DOI: 10.2337/db15-0214] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
650 Chong HK, Infante AM, Seo YK, Jeon TI, Zhang Y, Edwards PA, Xie X, Osborne TF. Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Res. 2010;38:6007-6017. [PMID: 20483916 DOI: 10.1093/nar/gkq397] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
651 Hu Y, Li C, Hou Y. Possible regulation of liver glycogen structure through the gut-liver axis by resistant starch: a review. Food Funct 2021;12:11154-64. [PMID: 34694313 DOI: 10.1039/d1fo02416g] [Reference Citation Analysis]
652 Chávez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology 2017;152:1679-1694.e3. [PMID: 28214524 DOI: 10.1053/j.gastro.2017.01.055] [Cited by in Crossref: 269] [Cited by in F6Publishing: 255] [Article Influence: 53.8] [Reference Citation Analysis]
653 Lu Y, Feskens EJ, Boer JM, Müller M. The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis 2010;210:14-27. [PMID: 19932478 DOI: 10.1016/j.atherosclerosis.2009.10.035] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
654 Vignozzi L, Morelli A, Cellai I, Filippi S, Comeglio P, Sarchielli E, Maneschi E, Vannelli GB, Adorini L, Maggi M. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. The Journal of Steroid Biochemistry and Molecular Biology 2017;165:277-92. [DOI: 10.1016/j.jsbmb.2016.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
655 Haeusler RA, Pratt-Hyatt M, Welch CL, Klaassen CD, Accili D. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab 2012;15:65-74. [PMID: 22197325 DOI: 10.1016/j.cmet.2011.11.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
656 Kohli R, Setchell KD, Kirby M, Myronovych A, Ryan KK, Ibrahim SH, Berger J, Smith K, Toure M, Woods SC. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 2013;154:2341-2351. [PMID: 23592746 DOI: 10.1210/en.2012-2069] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 11.0] [Reference Citation Analysis]
657 Albrecht S, Fleck AK, Kirchberg I, Hucke S, Liebmann M, Klotz L, Kuhlmann T. Activation of FXR pathway does not alter glial cell function. J Neuroinflammation 2017;14:66. [PMID: 28351411 DOI: 10.1186/s12974-017-0833-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
658 Sips FLP, Eggink HM, Hilbers PAJ, Soeters MR, Groen AK, van Riel NAW. In Silico Analysis Identifies Intestinal Transit as a Key Determinant of Systemic Bile Acid Metabolism. Front Physiol 2018;9:631. [PMID: 29951001 DOI: 10.3389/fphys.2018.00631] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
659 Machado MV, Cortez-pinto H. Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment? Liver Int 2014;34:1291-4. [DOI: 10.1111/liv.12578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
660 Prawitt J, Staels B. Bile Acid Sequestrants: Glucose-Lowering Mechanisms. Metabolic Syndrome and Related Disorders 2010;8:S-3-8. [DOI: 10.1089/met.2010.0096] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
661 Mastrangelo A, Martos-Moreno GÁ, García A, Barrios V, Rupérez FJ, Chowen JA, Barbas C, Argente J. Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations. Int J Obes (Lond) 2016;40:1494-502. [PMID: 27163744 DOI: 10.1038/ijo.2016.92] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
662 Düfer M, Hörth K, Wagner R, Schittenhelm B, Prowald S, Wagner TF, Oberwinkler J, Lukowski R, Gonzalez FJ, Krippeit-Drews P, Drews G. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 2012;61:1479-89. [PMID: 22492528 DOI: 10.2337/db11-0815] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 10.1] [Reference Citation Analysis]
663 Goldberg AA, Titorenko VI, Beach A, Sanderson JT. Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells. PeerJ. 2013;1:e122. [PMID: 23940835 DOI: 10.7717/peerj.122] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
664 Zhang Y. Farnesoid X receptor-Acting through bile acids to treat metabolic disorders. Drugs Future 2010;35:635-42. [PMID: 24465082 DOI: 10.1358/dof.2010.035.08.1520865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
665 Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov Today. 2012;17:988-997. [PMID: 22652341 DOI: 10.1016/j.drudis.2012.05.012] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 17.5] [Reference Citation Analysis]
666 Makishima M, Yamada S. The Bile Acid Derivatives Lithocholic Acid Acetate and Lithocholic Acid Propionate are Functionally Selective Vitamin D Receptor Ligands. Vitamin D. Elsevier; 2011. pp. 1509-24. [DOI: 10.1016/b978-0-12-381978-9.10079-4] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
667 Jimenez-Munoz CM, López M, Albericio F, Makowski K. Targeting Energy Expenditure-Drugs for Obesity Treatment. Pharmaceuticals (Basel) 2021;14:435. [PMID: 34066399 DOI: 10.3390/ph14050435] [Reference Citation Analysis]
668 Gautier T, de Haan W, Grober J, Ye D, Bahr MJ, Claudel T, Nijstad N, Van Berkel TJC, Havekes LM, Manns MP, Willems SM, Hogendoorn PCW, Lagrost L, Kuipers F, Van Eck M, Rensen PCN, Tietge UJF. Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice. J Lipid Res 2013;54:2195-205. [PMID: 23620138 DOI: 10.1194/jlr.M038141] [Cited by in Crossref: 31] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
669 Teng YC, Shen ZQ, Kao CH, Tsai TF. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World J Gastroenterol 2016; 22(1): 300-325 [PMID: 26755878 DOI: 10.3748/wjg.v22.i1.300] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
670 Brufau G, Stellaard F, Prado K, Bloks VW, Jonkers E, Boverhof R, Kuipers F, Murphy EJ. Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism. Hepatology 2010;52:1455-64. [PMID: 20725912 DOI: 10.1002/hep.23831] [Cited by in Crossref: 124] [Cited by in F6Publishing: 128] [Article Influence: 10.3] [Reference Citation Analysis]
671 Mukherjee A, Lordan C, Ross RP, Cotter PD. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes 2020;12:1802866. [PMID: 32835590 DOI: 10.1080/19490976.2020.1802866] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
672 Wu X, Li JY, Lee A, Lu YX, Zhou SY, Owyang C. Satiety induced by bile acids is mediated via vagal afferent pathways. JCI Insight 2020;5:132400. [PMID: 32699194 DOI: 10.1172/jci.insight.132400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
673 Staels B, Fonseca VA. Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Diabetes Care. 2009;32 Suppl 2:S237-S245. [PMID: 19875558 DOI: 10.2337/dc09-s355] [Cited by in Crossref: 182] [Cited by in F6Publishing: 83] [Article Influence: 15.2] [Reference Citation Analysis]
674 Zhang X, Zhu M, Xu B, Cui Y, Tian G, Shi Z, Ding M. Indirect electrochemical detection for total bile acids in human serum. Biosens Bioelectron 2016;85:563-7. [PMID: 27236139 DOI: 10.1016/j.bios.2016.05.055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
675 Qiu Q, Wang W, Zhao X, Chen Y, Zhao S, Zhu J, Xu X, Geng R. Design, synthesis and structure-activity relationship studies of novel partial FXR agonists for the treatment of fatty liver. Bioorg Chem 2020;104:104262. [PMID: 32919135 DOI: 10.1016/j.bioorg.2020.104262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
676 Wang DQ, Portincasa P, Neuschwander-Tetri BA. Steatosis in the liver. Compr Physiol 2013;3:1493-532. [PMID: 24265237 DOI: 10.1002/cphy.c130001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
677 Liu H, Pathak P, Boehme S, Chiang JL. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. J Lipid Res 2016;57:1831-44. [PMID: 27534992 DOI: 10.1194/jlr.M069807] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
678 Dong HS, Shen QB, Lan HY, Zhao W, Cao P, Chen P. Fecal Bile Acids Profile of Crewmembers Consuming the Same Space Food in a Spacecraft Simulator. Front Physiol 2021;12:593226. [PMID: 34658900 DOI: 10.3389/fphys.2021.593226] [Reference Citation Analysis]
679 Vaquero J, Briz O, Herraez E, Muntané J, Marin JJ. Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds. Biochim Biophys Acta 2013;1833:2212-9. [PMID: 23680185 DOI: 10.1016/j.bbamcr.2013.05.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
680 Frank DN, Bales ES, Monks J, Jackman MJ, MacLean PS, Ir D, Robertson CE, Orlicky DJ, McManaman JL. Perilipin-2 Modulates Lipid Absorption and Microbiome Responses in the Mouse Intestine. PLoS One. 2015;10:e0131944. [PMID: 26147095 DOI: 10.1371/journal.pone.0131944] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
681 Hutch CR, Sandoval DA. Physiological and molecular responses to bariatric surgery: markers